86 results on '"Teeratakulpisarn, N."'
Search Results
2. Neuropathy risk prior to therapy
- Author
-
Shikuma, CM, Gerschenson, M, Ananworanich, J, Valcour, VG, Teeratakulpisarn, N, Jadwattanakul, T, DeGruttola, V, Liang, C‐Y, McArthur, JC, Ebenezer, GJ, Chomchey, N, Praihirunkit, P, Hongchookiath, P, Mathajittiphun, P, Nakamoto, B, Hauer, P, Phanuphak, P, Phanuphak, N, and team, the SEARCH 003 protocol
- Subjects
Clinical Trials and Supportive Activities ,Neurosciences ,Clinical Research ,Prevention ,Peripheral Neuropathy ,HIV/AIDS ,Neurodegenerative ,Aging ,Evaluation of treatments and therapeutic interventions ,6.1 Pharmaceuticals ,Adult ,Age Distribution ,Anti-HIV Agents ,Body Mass Index ,Female ,HIV Seropositivity ,Humans ,Male ,Nerve Fibers ,Neurotoxicity Syndromes ,Peripheral Nervous System Diseases ,Polyneuropathies ,Predictive Value of Tests ,Stavudine ,Thailand ,antiretroviral naive ,epidermal nerve fibre density ,HIV ,neuropathy ,SEARCH 003 protocol team ,Clinical Sciences ,Virology - Abstract
ObjectivesDistal leg epidermal nerve fibre density (ENFD) is a validated predictor of small unmyelinated nerve fibre damage and neuropathy risk in HIV infection. As pre-existing damage may increase the risk of neuropathy following antiretroviral (ARV) therapy, particularly when the regimen contains stavudine (d4T), we assessed the relationship between ENFD and various parameters including mitochondrial factors in HIV-infected Thai individuals naïve to ARV therapy.MethodsDistal leg and proximal thigh ENFDs were quantified in HIV-infected Thai individuals without neuropathy prior to randomization to a HIV clinical trial that focused on mitochondrial toxicity issues. We assessed their association with various clinical and immunovirological parameters as well as with peripheral blood mononuclear cell (PBMC) mitochondrial (mt) DNA copies/cell, oxidative phosphorylation (OXPHOS) complex I (CI) and complex IV (CIV) enzyme activities, and mt 8-oxo-deoxyguanine (8-oxo-dG) break frequencies.ResultsIn 132 subjects, the median (interquartile range) ENFD (fibres/mm) values were 21.0 (16.2-26.6) for the distal leg and 31.7 (26.2-40.0) for the proximal thigh. By linear regression, lower CD4 count (P
- Published
- 2012
3. Determinants of epidermal nerve fibre density in antiretroviral-naïve HIV-infected individuals.
- Author
-
Shikuma, Cm, Gerschenson, M, Ananworanich, J, Valcour, Vg, Teeratakulpisarn, N, Jadwattanakul, T, Degruttola, V, Liang, C-Y, McArthur, Jc, Ebenezer, Gj, Chomchey, N, Praihirunkit, P, Hongchookiath, P, Mathajittiphun, P, Nakamoto, B, Hauer, P, Phanuphak, P, Phanuphak, N, and SEARCH 003 protocol team
- Subjects
SEARCH 003 protocol team ,Nerve Fibers ,Humans ,HIV Seropositivity ,Peripheral Nervous System Diseases ,Polyneuropathies ,Neurotoxicity Syndromes ,Stavudine ,Anti-HIV Agents ,Body Mass Index ,Predictive Value of Tests ,Age Distribution ,Adult ,Thailand ,Female ,Male ,antiretroviral naive ,epidermal nerve fibre density ,HIV ,neuropathy ,Virology ,Clinical Sciences - Abstract
ObjectivesDistal leg epidermal nerve fibre density (ENFD) is a validated predictor of small unmyelinated nerve fibre damage and neuropathy risk in HIV infection. As pre-existing damage may increase the risk of neuropathy following antiretroviral (ARV) therapy, particularly when the regimen contains stavudine (d4T), we assessed the relationship between ENFD and various parameters including mitochondrial factors in HIV-infected Thai individuals naïve to ARV therapy.MethodsDistal leg and proximal thigh ENFDs were quantified in HIV-infected Thai individuals without neuropathy prior to randomization to a HIV clinical trial that focused on mitochondrial toxicity issues. We assessed their association with various clinical and immunovirological parameters as well as with peripheral blood mononuclear cell (PBMC) mitochondrial (mt) DNA copies/cell, oxidative phosphorylation (OXPHOS) complex I (CI) and complex IV (CIV) enzyme activities, and mt 8-oxo-deoxyguanine (8-oxo-dG) break frequencies.ResultsIn 132 subjects, the median (interquartile range) ENFD (fibres/mm) values were 21.0 (16.2-26.6) for the distal leg and 31.7 (26.2-40.0) for the proximal thigh. By linear regression, lower CD4 count (P
- Published
- 2012
4. Evaluating the integration of telehealth in same-day antiretroviral initiation service during COVID-19 in Bangkok, Thailand
- Author
-
Amatavete, S., Lujintanon, S., Teeratakulpisarn, N., Thitipatarakorn1, S. Seekaew, P., Hanaree, C., Sripanjakun, J., Prabjuntuek, C., Kulsinsub, N., Peelay, J., Phanuphak, P., Phanuphak, N., and Ramautarsing, R.
- Subjects
Epidemics -- Control -- Thailand ,Telemedicine -- Methods ,Highly active antiretroviral therapy -- Methods ,HIV infection -- Diagnosis -- Care and treatment ,Health - Abstract
Background: Same-day antiretroviral therapy (SDART) initiation has been implemented since 2017 at the Thai Red Cross Anonymous Clinic (TRCAC), an HIV testing centre in Bangkok, Thailand. Clients who are willing [...]
- Published
- 2021
- Full Text
- View/download PDF
5. Acceptability and satisfaction of self-collection for chlamydia and gonorrhoea testing among transgender women in the Tangerine Clinic, Thailand: shifting toward the new normal
- Author
-
Hiransuthikul, A., Janamnuaysook, R., Himmad, L., Taya, C., Teeratakulpisarn, N., Thammajaruk, N., Avery, M., Mills, S., Ramautarsing, R., and Phanuphak, N.
- Subjects
Women -- Health aspects ,Self-examination, Medical -- Surveys ,Patient satisfaction -- Surveys ,Transgender people -- Care and treatment -- Surveys ,Chlamydia infections -- Diagnosis -- Surveys ,Gonorrhea -- Diagnosis -- Surveys ,Health - Abstract
Background: Provider-collected swabs are an unappealing procedure for many transgender women due and may have led to suboptimal rates of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) testing. Self-collection for [...]
- Published
- 2021
- Full Text
- View/download PDF
6. Hormone levels among transgender women and transgender men in a transgender-led, integrated, gender-affirming care and sexual health service at Tangerine Clinic in Bangkok, Thailand: a real-world analysis
- Author
-
Hiransuthikul, A., Janamnuaysook, R., Getwongsa, P., Peelay, J., Teeratakulpisarn, N., Avery, M., Mills, S., Ramautarsing, R., and Phanuphak, N.
- Subjects
Hormone therapy -- Patient outcomes ,Transgender people -- Care and treatment ,Hormones, Sex -- Measurement -- Health aspects ,Health - Abstract
Background: Gender-affirming hormone therapy (GAHT) is used among many transgender individuals who would like to achieve physical changes - feminizing hormone therapy (FHT) for transgender women and masculinizing hormone therapy [...]
- Published
- 2021
- Full Text
- View/download PDF
7. Anal squamous intraepithelial lesions among HIV positive and HIV negative men who have sex with men in Thailand
- Author
-
Li, A H, Phanuphak, N, Sahasrabuddhe, V V, Chaithongwongwatthana, S, Vermund, S H, Jenkins, C A, Shepherd, B E, Teeratakulpisarn, N, van der Lugt, J, Avihingsanon, A, Ruxrungtham, K, Shikuma, C, Phanuphak, P, and Ananworanich, J
- Published
- 2009
- Full Text
- View/download PDF
8. Cervical cytological abnormalities and HPV infection in perinatally HIV-infected adolescents
- Author
-
Ananworanich, J., Prasitsuebsai, W., Stephen Kerr, Hansudewechakul, R., Teeratakulpisarn, N., Saisawat, K., Ramautarsing, R., Achalapong, J., Pussadee, K., Keadpudsa, S., Mackay, T., Pankam, T., Rodbamrung, P., Petdachai, W., Chokephaibulkit, K., Sohn, A. H., Phanuphak, N., and Other departments
- Abstract
Behaviourally HIV-infected adolescent females are at higher risk for abnormal cervical cytology and HPV infection compared to those who are uninfected, but data on perinatally HIV-infected adolescent females are lacking. Cervical cytology, HPV infection and E6/E7 mRNA were assessed in sexually active 12-24-year-old adolescent females: perinatally HIV-infected (group 1, n = 40), behaviourally HIV-infected (group 2, n = 10), and HIV-uninfected (group 3, n = 10). Median age was lower in group 1 (18 years) than in groups 2 (24 years) and 3 (20.5 years) (P < 0.001), and median time since sexual debut was shorter: 2 vs 5 vs 4 years (P < 0.001). More trial participants in group 1 than group 2 were on antiretrovirals (90% vs 70%; P
- Published
- 2015
9. Cervical cytological abnormalities and HPV infection in perinatally HIV-infected adolescents.
- Author
-
Ananworanich, J, Prasitsuebsai, W, Kerr, SJ, Hansudewechakul, R, Teeratakulpisarn, N, Saisawat, K, Ramautarsing, R, Achalapong, J, Pussadee, K, Keadpudsa, S, Mackay, T, Pankam, T, Rodbamrung, P, Petdachai, W, Chokephaibulkit, K, Sohn, AH, Phanuphak, N, Ananworanich, J, Prasitsuebsai, W, Kerr, SJ, Hansudewechakul, R, Teeratakulpisarn, N, Saisawat, K, Ramautarsing, R, Achalapong, J, Pussadee, K, Keadpudsa, S, Mackay, T, Pankam, T, Rodbamrung, P, Petdachai, W, Chokephaibulkit, K, Sohn, AH, and Phanuphak, N
- Abstract
BACKGROUND: Behaviourally HIV-infected adolescent females are at higher risk for abnormal cervical cytology and HPV infection compared to those who are uninfected, but data on perinatally HIV-infected adolescent females are lacking. METHODS: Cervical cytology, HPV infection and E6/E7 mRNA were assessed in sexually active 12-24-year-old adolescent females: perinatally HIV-infected (group 1, n = 40), behaviourally HIV-infected (group 2, n = 10), and HIV-uninfected (group 3, n = 10). RESULTS: Median age was lower in group 1 (18 years) than in groups 2 (24 years) and 3 (20.5 years) (P < 0.001), and median time since sexual debut was shorter: 2 vs 5 vs 4 years (P < 0.001). More trial participants in group 1 than group 2 were on antiretrovirals (90% vs 70%; P <0.001). Abnormal cervical cytology (atypical squamous cells of undetermined significance and higher) was observed in 30% (group 1), 40% (group 2) and 30% (group 3) (P = 0.92), whereas high-risk HPV infection was observed in 45%, 45% and 40%, respectively (P = 1.00). Positive E6/E7 mRNA was found in 28% of group 1, but not in other groups. High-risk HPV infection predicted abnormal cytology in all groups [OR 6.77, 95% confidence interval (CI) 1.99-23.0; P = 0.001). Additionally, plasma HIV RNA ≥50 copies/mL (OR 13.3, 95% CI 1.16-153.06; P = 0.04) predicted abnormal cytology in HIV-infected adolescent females. CONCLUSIONS: Despite the younger age and shorter time since sexual debut, cervical cytological abnormalities and HPV infection were as common in perinatally HIV-infected as in behaviourally infected and uninfected adolescents. HPV vaccination, pre-cancer screening and antiretroviral treatment in HIV-infected female adolescents should be implemented to minimise the risk of cervical cancer.
- Published
- 2015
10. Ethnic differences in epidermal nerve fiber density
- Author
-
Shikuma, CM, Mcarthur, JC, Ebenezer, GJ, Ananworanich, J, Teeratakulpisarn, N, Jadwattanakul, T, Valcour, VG, Bennett, K, and Phanuphak, N
- Published
- 2013
11. Change in Brain Magnetic Resonance Spectroscopy after Treatment during Acute HIV Infection
- Author
-
Sailasuta, N, Ross, W, Ananworanich, J, Chalermchai, T, DeGruttola, V, Lerdlum, S, Pothisri, M, Busovaca, E, Ratto-Kim, S, Jagodzinski, L, Spudich, S, Michael, N, Kim, JH, Valcour, V, Phanuphak, N, Teeratakulpisarn, N, Fletcher, JLK, Suttichom, D, Pinyakorn, S, Rattanamanee, S, Chomchey, N, Mangum, P, Ubolyam, S, Suwanwela, NC, Chaisinanunkul, N, Suthiponpaisan, U, Sutthapas, C, deSouza, M, Ngauy, V, Trichavaroj, R, Akapirat, S, Marovich, M, Wendelken, L, Liu, C, Mun, E, and Miller, B
- Abstract
Objective: Single voxel proton magnetic resonance spectroscopy (MRS) can be used to monitor changes in brain inflammation and neuronal integrity associated with HIV infection and its treatments. We used MRS to measure brain changes during the first weeks following HIV infection and in response to antiretroviral therapy (ART). Methods: Brain metabolite levels of N-acetyl aspartate (NAA), choline (tCHO), creatine (CR), myoinositol (MI), and glutamate and glutamine (GLX) were measured in acute HIV subjects (n = 31) and compared to chronic HIV+individuals (n = 26) and HIV negative control subjects (n = 10) from Bangkok, Thailand. Metabolites were measured in frontal gray matter (FGM), frontal white matter (FWM), occipital gray matter (OGM), and basal ganglia (BG). Repeat measures were obtained in 17 acute subjects 1, 3 and 6 months following initiation of ART. Results: After adjustment for age we identified elevated BG tCHO/CR in acute HIV cases at baseline (median 14 days after HIV infection) compared to control (p = 0.0014), as well as chronic subjects (p = 0.0023). A similar tCHO/CR elevation was noted in OGM; no other metabolite abnormalities were seen between acute and control subjects. Mixed longitudinal models revealed resolution of BG tCHO/CR elevation after ART (p = 0.022) with tCHO/CR similar to control subjects at 6 months. Interpretation: We detected cellular inflammation in the absence of measurable neuronal injury within the first month of HIV infection, and normalization of this inflammation following acutely administered ART. Our findings suggest that early ART may be neuroprotective in HIV infection by mitigating processes leading to CNS injury. © 2012 Sailasuta et al.
- Published
- 2012
12. Interest in the 'Test and Treat' strategy for HIV prevention among men who have sex with men living in Bangkok
- Author
-
Maek?A?Nantawat, W, Phanuphak, N, Teeratakulpisarn, N, Kanteeranon, T, Chaiya, O, Mansawat, T, Ananworanich, J, and Phanuphak, P
- Subjects
HIV testing -- Methods ,Antiviral agents -- Dosage and administration ,Sexually transmitted diseases -- Prevention ,MSM (Men who have sex with men) -- Health aspects -- Social aspects ,Health - Abstract
Background: The current HIV epidemic in Thailand is primarily driven by new cases among men who have sex with men (MSM). HPTN052 study demonstrated 96% efficacy of immediate antiretroviral therapy (ART) to reduce HIV transmission among serodiscordant heterosexual couples. As a result, universal HIV testing and immediate ART has emerged as a strategy to reduce HIV transmission in certain at‐risk populations. The acceptability of this strategy, however, is unknown in MSM. Methods: From August 2011‐March 2012, we conducted a cross‐sectional study using self‐administered questionnaires to assess attitudes towards universal HIV testing and immediate ART among MSM VCT clients in Bangkok. Participants were asked to complete the questionnaires prior to and after knowing their HIV status. The study was approved by the Institutional Review Board of the Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. Results: Of 342 MSM, the median age (IQR) was 26 (22–31) years, and 34.2% had bachelor's degree or higher. Previous HIV testing was reported by 69.9%, 35.2% of which had HIV testing annually. The most common reasons for previous HIV testing included perceived risk behaviors (63.6%), annual health checkup (26.4%), and partner's request (13.8%). Prior to receiving pre‐test counseling, 74.4% expressed interest to get regular HIV testing. Health benefits from testing (59.6%), free testing (36.5%), and speedy service (35.7%) were the most common persuasive reasons to come for regular HIV testing. Longevity (73.1%) and prevention of HIV transmission to others (58.4%) were reasons for interest in immediate ART (if tested positive) program while costs (37.0%) and life‐long burden (36.7%) were cited as main barriers. Among MSM who tested HIV‐positive (n=45, 13.2%), the interest to participate in immediate ART program was very high both before and after knowing their HIV status (86.7% vs 93.3%, p=0.371). Among HIV‐negative MSM, the interest to participate in regular HIV testing program significantly increased after knowing HIV status (83.4% vs 77.0%, p Conclusions: MSM in Bangkok showed high level of interest in the “Test and Treat” strategy for HIV prevention. Knowing one's HIV status affected the interest to access regular HIV testing program., Reference Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV‐1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493–505. DOI: [...]
- Published
- 2012
- Full Text
- View/download PDF
13. Prevalence of anal squamous intraepithelial lesions in HIV-positive and HIV-negative men who have sex with men in Thailand.
- Author
-
Chalermchai, T., primary, Li, A. H., additional, Ananworanich, J., additional, Teeratakulpisarn, N., additional, Sathainthammawit, W., additional, Pakam, C., additional, Chaithongwongwatthana, S., additional, Shikuma, C., additional, Phanuphak, P., additional, and Phanuphak, N., additional
- Published
- 2010
- Full Text
- View/download PDF
14. Bloodstream infections among HIV-infected outpatients, Southeast Asia.
- Author
-
Varma JK, McCarthy KD, Tasaneeyapan T, Monkongdee P, Kimerling ME, Buntheoun E, Sculier D, Keo C, Phanuphak P, Teeratakulpisarn N, Udomsantisuk N, Dung NH, Lan NT, Yen NT, Cain KP, Varma, Jay K, McCarthy, Kimberly D, Tasaneeyapan, Theerawit, Monkongdee, Patama, and Kimerling, Michael E
- Abstract
Bloodstream infections (BSIs) are a major cause of illness in HIV-infected persons. To evaluate prevalence of and risk factors for BSIs in 2,009 HIV-infected outpatients in Cambodia, Thailand, and Vietnam, we performed a single Myco/F Lytic blood culture. Fifty-eight (2.9%) had a clinically significant BSI (i.e., a blood culture positive for an organism known to be a pathogen). Mycobacterium tuberculosis accounted for 31 (54%) of all BSIs, followed by fungi (13 [22%]) and bacteria (9 [16%]). Of patients for whom data were recorded about antiretroviral therapy, 0 of 119 who had received antiretroviral therapy for ≥14 days had a BSI, compared with 3% of 1,801 patients who had not. In multivariate analysis, factors consistently associated with BSI were fever, low CD4+ T-lymphocyte count, abnormalities on chest radiograph, and signs or symptoms of abdominal illness. For HIV-infected outpatients with these risk factors, clinicians should place their highest priority on diagnosing tuberculosis. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
15. Yield of Acid-fast Smear and Mycobacterial Culture for Tuberculosis Diagnosis in People with Human Immunodeficiency Virus.
- Author
-
Monkongdee P, McCarthy KD, Cain KP, Tasaneeyapan T, Dung NH, Lan NT, Yen NT, Teeratakulpisarn N, Udomsantisuk N, Heilig C, and Varma JK
- Abstract
Rationale: The World Health Organization recently revised its recommendations for tuberculosis (TB) diagnosis in people with HIV. Most studies cited to support these policies involved HIV-uninfected patients and only evaluated sputum specimens. Objectives: To evaluate the performance of acid-fast bacilli smear and mycobacterial culture on sputum and nonsputum specimens for TB diagnosis in a cross-sectional survey of HIV-infected patients. Methods: In Thailand and Vietnam, we enrolled people with HIV regardless of signs or symptoms. Enrolled patients provided three sputum, one urine, one stool, one blood, and, for patients with palpable peripheral adenopathy, one lymph node aspirate specimen for acid-fast bacilli microscopy and mycobacterial culture on solid and broth-based media. We classified any patient with at least one specimen culture positive for Mycobacterium tuberculosis as having TB. Measurements and Main Results: Of 1,060 patients enrolled, 147 (14%) had TB. Of 126 with pulmonary TB, the incremental yield of performing a third sputum smear over two smears was 2% (95% confidence interval, 0-6), 90 (71%) patients were detected on broth-based culture of the first sputum specimen, and an additional 21 (17%) and 12 (10%) patients were diagnosed with the second and third specimens cultured. Of 82 lymph nodes cultured, 34 (42%) grew M. tuberculosis. In patients with two negative sputum smears, broth-based culture of three sputum specimens had the highest yield of any testing strategy. Conclusions: In people with HIV living in settings where mycobacterial culture is not routinely available to all patients, a third sputum smear adds little to the diagnosis of TB. Broth-based culture of three sputum specimens diagnoses most TB cases, and lymph node aspiration provides the highest incremental yield of any nonpulmonary specimen test for TB. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
16. Associations between corticosteroid dosage and clinical outcomes in patients with hypoxemic COVID-19 pneumonia: A retrospective cohort study.
- Author
-
Teeratakulpisarn N, Chiewroongroj S, Naorungroj T, and Ratanarat R
- Subjects
- Humans, Female, Male, Retrospective Studies, Middle Aged, Aged, SARS-CoV-2 isolation & purification, Treatment Outcome, Dose-Response Relationship, Drug, Aged, 80 and over, Hospital Mortality, COVID-19 Drug Treatment, Dexamethasone administration & dosage, Dexamethasone therapeutic use, Dexamethasone adverse effects, COVID-19 mortality, COVID-19 complications, Adrenal Cortex Hormones administration & dosage, Adrenal Cortex Hormones adverse effects, Adrenal Cortex Hormones therapeutic use, Hypoxia drug therapy
- Abstract
Background: Corticosteroids are commonly used to treat COVID-19 patients with hypoxemia, and clinicians have adjusted the corticosteroid intensity on the basis of clinical needs. However, neither the optimal dose nor the duration of treatment has been recommended., Objective: To investigate whether cumulative doses of corticosteroids, measured as dexamethasone-equivalent doses over the first 14 days, impact outcomes in patients with COVID-19 pneumonia., Methods: We conducted a retrospective cohort study of COVID-19 pneumonia patients admitted between April 1st, 2020, and September 30th, 2021. The study focused on the type and dose of corticosteroid administered during the initial 14 days, clinical outcomes, and complications. The primary outcome was in-hospital mortality., Results: Among 271 patients, the mean cumulative dexamethasone-equivalent dose was 158 (119.9-197.25) mg in survivors and 185 (131.7-222.0) mg in nonsurvivors. Univariate analysis revealed that the cumulative dexamethasone-equivalent dose was a risk factor for in-hospital mortality. However, this association did not hold true in the multivariate analysis. After the cumulative dexamethasone-equivalent dose was categorized into quartiles, the moderate dosage (126.01-165.00 mg) in the second quartile was found to be associated with the lowest in-hospital mortality (16.2%). Higher cumulative dexamethasone-equivalent doses were associated with longer hospital and ICU stays and fewer ventilator-free days (p < 0.001). Doses exceeding 165 mg were associated with an increased risk of hospital-acquired infections (p < 0.001)., Conclusions: The cumulative dexamethasone-equivalent dose during the first 14 days is not associated with in-hospital mortality in hypoxemic COVID-19 patients. However, higher cumulative doses exceeding 165 mg are associated with an increased risk of in-hospital mortality and secondary hospital-acquired infections., Competing Interests: The authors have declared that no competing interests exist., (Copyright: © 2024 Teeratakulpisarn et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2024
- Full Text
- View/download PDF
17. Efficacy of additional hemoperfusion in hospitalized patients with severe to critical COVID-19 disease.
- Author
-
Chiewroongroj S, Ratanarat R, Naorungroj T, Teeratakulpisarn N, and Theeragul S
- Subjects
- Humans, Male, Female, Middle Aged, Aged, Respiration, Artificial, SARS-CoV-2 isolation & purification, Treatment Outcome, Length of Stay, Cytokines blood, Hospitalization, Intensive Care Units, Retrospective Studies, Severity of Illness Index, COVID-19 therapy, COVID-19 mortality, COVID-19 complications, Hemoperfusion methods, Hospital Mortality
- Abstract
The evidence supporting additional hemoperfusion (HP) with cytokine adsorbents for improving clinical outcomes in severe to critical coronavirus disease 2019 (COVID-19) patients remains limited. We compared severe to critical COVID-19 patients who received additional HP with a cytokine adsorbent to matched cases receiving standard medical treatment (SMT). The primary outcome was hospital mortality. In our study, we matched 45 patients who received additional HP 1:1 with the SMT group based on key clinical parameters. The hospital mortality rates did not differ between the groups (33% vs 38%, p = 0.83). The HP group had a significantly shorter ICU stay (22 vs 32 days; p = 0.017) and reduced mechanical ventilation duration (15 vs 35 days; p < 0.001). Additionally, the incidence of pulmonary complications (20% vs 42%; p = 0.04), sepsis (38% vs 64%; p = 0.02), and disseminated intravascular coagulopathy (DIC) (13% vs 33%; p = 0.046) were significantly lower in the HP group. In conclusion, among severe to critical COVID-19 patients, additional HP with a cytokine adsorbent did not improve hospital mortality. However, it reduced ICU length of stay, mechanical ventilator days, and incidences of lung complications, sepsis, and DIC. Trial registration: TCTR20231002006. Registered 02 October 2023 (retrospectively registered)., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
18. Prevalence and incidence of anal high-grade squamous intraepithelial lesions in a cohort of cisgender men and transgender women who have sex with men diagnosed and treated during acute HIV acquisition in Bangkok, Thailand.
- Author
-
Thitipatarakorn S, Teeratakulpisarn N, Nonenoy S, Klinsukontakul A, Suriwong S, Makphol J, Hongchookiat P, Chaya-Ananchot T, Chinlaertworasiri N, Mingkwanrungruang P, Sacdalan C, Poltavee K, Pankam T, Kerr SJ, Ramautarsing R, Colby D, and Phanuphak N
- Subjects
- Humans, Thailand epidemiology, Male, Adult, Prevalence, Incidence, Female, Young Adult, Anus Neoplasms epidemiology, Papillomaviridae isolation & purification, Papillomaviridae genetics, Papillomavirus Infections epidemiology, Cohort Studies, Biopsy, Genotype, Anal Canal pathology, Anal Canal virology, HIV Infections drug therapy, HIV Infections epidemiology, HIV Infections complications, Transgender Persons statistics & numerical data, Homosexuality, Male statistics & numerical data, Squamous Intraepithelial Lesions epidemiology, Squamous Intraepithelial Lesions pathology
- Abstract
Introduction: Men who have sex with men (MSM), especially those living with HIV, are at an increased risk of anal cancer. The prevalence and incidence of its precursor, anal high-grade squamous intraepithelial lesions (HSILs), among MSM who started antiretroviral therapy during acute HIV acquisition are yet to be explored., Methods: Participants in an acute HIV acquisition cohort in Bangkok, Thailand, who agreed to take part in this study, were enrolled. All participants were diagnosed and started antiretroviral therapy during acute HIV acquisition. Human papillomavirus (HPV) genotyping and high-resolution anoscopy, followed by anal biopsy as indicated, were done at baseline and 6-monthly visits., Results: A total of 89 MSM and four transgender women were included in the analyses. Median age at enrolment was 26 years. Baseline prevalence of histologic anal HSIL was 11.8%. With a total of 147.0 person-years of follow-up, the incidence of initial histologic anal HSIL was 19.7 per 100 person-years. Factors associated with incident anal HSIL were anal HPV 16 (adjusted hazards ratio [aHR] 4.33, 95% CI 1.03-18.18), anal HPV 18/45 (aHR 6.82, 95% CI 1.57-29.51), other anal high-risk HPV (aHR 4.23, 95% CI 1.27-14.14), syphilis infection (aHR 4.67, 95% CI 1.10-19.90) and CD4 count <350 cells/mm
3 (aHR 3.09, 95% CI 1.28-7.48)., Conclusions: With antiretroviral therapy initiation during acute HIV acquisition, we found the prevalence of anal HSIL among cisgender men and transgender women who have sex with men to be similar to those without HIV. Subsequent anal HSIL incidence, although lower than that of those with chronic HIV acquisition, was still higher than that of those without HIV. Screening for and management of anal HSIL should be a crucial part of long-term HIV care for all MSM., (© 2024 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of International AIDS Society.)- Published
- 2024
- Full Text
- View/download PDF
19. The effects of bivalent human papillomavirus (HPV) vaccination on high-risk anogenital HPV infection among sexually active female adolescents with and without perinatally acquired HIV.
- Author
-
Ounchanum P, Ounchanum P, Achalapong J, Achalapong J, Teeraananchai S, Teeraananchai S, Gatechompol S, Gatechompol S, Phongsamart W, Phongsamart W, Chokephaibulkit K, Chokephaibulkit K, Tran DNH, Tran DNH, Dang HLD, Dang HLD, Teeratakulpisarn N, Teeratakulpisarn N, Chalermchockcharoenkit A, Chalermchockcharoenkit A, Singtoroj T, Singtoroj T, Sohn AH, Sohn AH, Phanuphak N, and Phanuphak N
- Subjects
- Child, Pregnancy, Adolescent, Humans, Female, HIV, Vaccination, Prevalence, Human Papillomavirus Viruses, Papillomavirus Infections epidemiology, Papillomavirus Infections prevention & control, Papillomavirus Infections complications, HIV Infections complications, Sexually Transmitted Diseases complications, Papillomavirus Vaccines therapeutic use
- Abstract
Background: Females with perinatal HIV (PHIV) infection are at elevated risk for anogenital high-risk human papillomavirus (HR-HPV) infection. Limited data are available around the effect of the HPV vaccination after initiation of sexual activity among PHIV youth. This study aims to assess the impact of a bivalent HPV vaccination on the persistence of anogenital HR-HPV among sexually active female PHIV youth and matched HIV-negative controls aged 12-24years in Thailand and Vietnam., Methods: During a 3-year study, prevalent, incident, and persistent HR-HPV infection were assessed at annual visits. A subset of participants received a bivalent HPV vaccine. Samples were taken for HPV testing from the vagina, cervix, and anus. HR-HPV persistence was defined as the detection of the same genotype(s) at any anogenital compartment over≥two consecutive visits., Results: Of the 93 PHIV and 99 HIV-negative female youth enrolled in this study, 25 (27%) PHIV and 22 (22%) HIV-negative youth received a HPV vaccine. Persistent infection with any HR-HPV type was significantly lower among PHIV youth who received the vaccine compared to those who did not (33%vs 61%, P =0.02); a difference was not observed among HIV-negative youth (35%vs 50%, P =0.82). PHIV infection (adjusted prevalence ratio [aPR] 2.31, 95% CI 1.45-3.67) and not receiving a HPV vaccine (aPR, 1.19, 95%CI 1.06-1.33) were associated with persistent anogenital HR-HPV infection., Conclusions: Bivalent HPV vaccination after initiation of sexual activity was associated with reduced persistence of anogenital HR-HPV infection in Southeast Asian PHIV female youth, which may be related to vaccine cross-protection. Primary and catch-up HPV vaccinations should be prioritised for children and youth with HIV.
- Published
- 2024
- Full Text
- View/download PDF
20. Estradiol and Testosterone Concentrations Among Thai Transgender Women in a Transgender-Led, Integrated Gender-Affirming Care and Sexual Health Clinic: A Real-World Analysis.
- Author
-
Hiransuthikul A, Janamnuaysook R, Getwongsa P, Peelay J, Samitpol K, Amatsombat T, Chumnanwet P, Chancham A, Kongkapan J, Rueannak J, Himma L, Srimanus P, Teeratakulpisarn N, Avery M, Wansom T, Mills S, Ramautarsing RA, and Phanuphak N
- Abstract
Purpose: Feminizing hormone therapy (FHT) is used by many transgender women as a pharmacological method to mitigate gender dysphoria. However, information on hormone concentrations among those who use FHT is lacking. We aimed to determine the proportion of Thai transgender women who were using FHT who had hormone concentrations within target ranges in a real-world clinic setting., Methods: Transgender women who attended Tangerine Clinic in Bangkok, Thailand, reported current use of FHT at clinic entry, and tested for both blood estradiol (E2) and total testosterone (TT) concentrations were included in the analysis. Hormone target concentrations were defined as 100-200 pg/mL for E2 and <50 ng/dL for TT., Results: Of 1534 transgender women included, 2.5% had undergone orchiectomy, and 524 (34.2%) had any hormones within target concentrations. Median (interquartile range) E2 and TT concentrations at baseline were 29 (14.3-45.3) pg/mL and 298.5 (22-646) ng/dL, respectively. Among those who had any hormones within target concentrations, 28 (1.8%), 11 (0.7%), and 485 (31.6%) had both hormones, only E2, and only TT within target concentrations, respectively. Among 1010 (65.8%) transgender women who had neither hormone within target concentrations, 989 (64.5%) and 21 (1.4%) had suboptimal and supraphysiological E2 concentrations, respectively. Among those who came to at least one follow-up visit ( n =302), 165 (54.6%) transgender women managed to achieve or maintain either hormone within target concentrations., Conclusion: One-third of Thai transgender women who were using FHT had any hormones within target concentrations at baseline in this real-world setting study. Most transgender women who had neither hormone within target concentrations had suboptimal rather than supraphysiological E2 concentrations. More than half managed to achieve or maintain at least one hormone concentration within target concentrations at follow-up visits, suggesting a positive effect from attending a trans-led, integrated gender-affirming care and sexual health service., Competing Interests: All authors declare no competing interests related to this work., (© Akarin Hiransuthikul et al. 2022; Published by Mary Ann Liebert, Inc.)
- Published
- 2022
- Full Text
- View/download PDF
21. Same-day antiretroviral therapy initiation hub model at the Thai Red Cross Anonymous Clinic in Bangkok, Thailand: an observational cohort study.
- Author
-
Seekaew P, Phanuphak N, Teeratakulpisarn N, Amatavete S, Lujintanon S, Teeratakulpisarn S, Pankam T, Nampaisan O, Jomja P, Prabjunteuk C, Plodgratoke P, Ramautarsing R, and Phanuphak P
- Subjects
- Cohort Studies, Humans, Red Cross, Thailand, Anti-HIV Agents therapeutic use, HIV Infections diagnosis, HIV Infections drug therapy
- Abstract
Introduction: WHO has recommended rapid antiretroviral therapy (ART) initiation, including same-day ART (SDART). However, data on the feasibility in real-world settings are limited. We implemented a cohort study at a stand-alone HIV testing centre to examine its applicability and effectiveness., Methods: Data were collected from the Thai Red Cross Anonymous Clinic in Bangkok, Thailand, between July 2017 and July 2018 from clients who were ART-naïve and could return for follow-up visits. Baseline laboratory tests and chest X-ray were performed according to national guidelines, and clinical eligibility was determined based on physical examination and chest X-ray findings. Primary outcomes were retention in care and viral load suppression at 3, 6 and 12 months., Results: During the study period, 2427 people tested HIV positive. Of these, 2107 (2207/2427, 86.8%) met logistical criteria, and 1904 (1904/2427, 78.5%) agreed to SDART. One thousand seven hundred and twenty-nine (1729/2427, 71.2%) were placed on ART, with 1257 received same-day initiation and 1576 initiated ART within 7 days; 1198 clients were successfully referred to free, sustained ART sites. Retention among eligible clients who accepted SDART service at months 3, 6 and 12 was 79.8%, 75.2% and 75.3%, respectively., Conclusions: Same-day ART initiation hub model at a stand-alone HIV testing centre in an urban setting in Bangkok, Thailand, is highly feasible and has a potential for scaling up., Clinical Trial Number: NCT04032028., (© 2021 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society.)
- Published
- 2021
- Full Text
- View/download PDF
22. Evaluation of the integration of telehealth into the same-day antiretroviral therapy initiation service in Bangkok, Thailand in response to COVID-19: a mixed-method analysis of real-world data.
- Author
-
Amatavete S, Lujintanon S, Teeratakulpisarn N, Thitipatarakorn S, Seekaew P, Hanaree C, Sripanjakun J, Prabjuntuek C, Suwannarat L, Phattanathawornkool T, Photisan N, Suriwong S, Avery M, Mills S, Phanuphak P, Phanuphak N, and Ramautarsing RA
- Subjects
- Humans, SARS-CoV-2, Thailand, Anti-HIV Agents therapeutic use, COVID-19, HIV Infections diagnosis, HIV Infections drug therapy, Telemedicine
- Abstract
Introduction: Same-day antiretroviral therapy (SDART) initiation has been implemented at the Thai Red Cross Anonymous Clinic (TRCAC) in Bangkok, Thailand, since 2017. HIV-positive, antiretroviral therapy (ART)-naïve clients who are willing and clinically eligible start ART on the day of HIV diagnosis. In response to the first wave of the coronavirus disease 2019 (COVID-19) outbreak in March 2020, telehealth follow-up was established to comply with COVID-19 preventive measures and allow service continuation. Here, we evaluate its implementation., Methods: Pre-COVID-19 (until February 2020) clients who initiated SDART received a 2-week ART supply and returned to the clinic for evaluation before being referred to long-term ART maintenance facilities. If no adverse events (AEs) occurred, another 8-week ART supply was provided while referral was arranged. During the first wave of COVID-19 (March-May 2020), clients received a 4-week ART supply and the option of conducting follow-up consultation and physical examination via video call. Clients with severe AEs were required to return to TRCAC; those without received another 6-week ART supply by courier to bridge transition to long-term facilities. This adaptation continued post-first wave (May-August 2020). Routine service data were analysed using data from March to August 2019 for the pre-COVID-19 period. Interviews and thematic analysis were conducted to understand experiences of clients and providers, and gain feedback for service improvement., Results: Of 922, 183 and 321 eligible clients from the three periods, SDART reach [89.9%, 96.2% and 92.2% (p = 0.018)] and ART initiation rates [88.1%, 90.9% and 94.9% (p<0.001)] were high. ART uptake, time to ART initiation and rates of follow-up completion improved over time. After the integration, 35.3% received the telehealth follow-up. The rates of successful referral to a long-term facility (91.8% vs. 95.3%, p = 0.535) and retention in care at months 3 (97.5% vs. 98.0%, p = 0.963) and 6 (94.1% vs. 98.4%, p = 0.148) were comparable for those receiving in-person and telehealth follow-up. Six clients and nine providers were interviewed; six themes on service experience and feedback were identified., Conclusions: Telehealth follow-up with ART delivery for SDART clients is a feasible option to differentiate ART initiation services at TRCAC, which led to its incorporation into routine service., (© 2021 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society.)
- Published
- 2021
- Full Text
- View/download PDF
23. Acceptability and satisfaction towards self-collection for chlamydia and gonorrhoea testing among transgender women in Tangerine Clinic, Thailand: shifting towards the new normal.
- Author
-
Hiransuthikul A, Janamnuaysook R, Himma L, Taya C, Amatsombat T, Chumnanwet P, Samitpol K, Chancham A, Kongkapan J, Rueannak J, Getwongsa P, Srimanus P, Teeratakulpisarn N, Thammajaruk N, Avery M, Wansom T, Mills S, Ramautarsing RA, and Phanuphak N
- Subjects
- Adult, COVID-19, Chlamydia Infections epidemiology, Female, Gonorrhea epidemiology, Humans, Male, Pandemics, SARS-CoV-2, Self Care, Thailand epidemiology, Chlamydia Infections diagnosis, Chlamydia trachomatis isolation & purification, Gonorrhea diagnosis, Neisseria gonorrhoeae isolation & purification, Patient Acceptance of Health Care, Personal Satisfaction, Specimen Handling methods, Transgender Persons
- Abstract
Introduction: Provider-collected swabs are an unappealing procedure for many transgender women and may have led to suboptimal rates of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) testing. Self-collection for CT/NG testing is recommended for men who have sex with men. However, the information on acceptability and clinical performance to support a recommendation for transgender women is lacking. We aimed to determine the acceptability and satisfaction towards self-collection for CT/NG testing among Thai transgender women., Methods: Thai transgender women who attended Tangerine Clinic (a transgender-led, integrated, gender-affirming care and sexual health services clinic in Bangkok, Thailand) between May and July 2020 and had condomless sexual intercourse within the past six months were offered to collect urine and perform self-swabs of pharyngeal, rectal, and if applicable, neovaginal compartments for pooled nucleic acid amplification testing for CT/NG infections. Participants received a diagram, video and oral instructions about how to perform self-collection procedure. Those who accepted self-collection were also offered to receive provider collection to evaluate the performance between the two methods. Self-administered questionnaires were used to assess satisfaction., Results: Among 216 transgender women enrolled, 142 (65.7%) accepted self-collection. All who accepted had pharyngeal, rectal and urine samples collected. Of 31 transgender women who had undergone genital surgery, 28 (90.3%) accepted neovaginal self-swab. The acceptance rate increased from 46.2% in May to 84.5% in July 2020. One participant had an invalid result. All transgender women who accepted self-collection could perform it without assistance, and 82.8% were highly satisfied with the method. None reported dissatisfaction. Due to the COVID-19 pandemic, provider collection services were discontinued early, and only eight transgender women were able to perform both methods for performance evaluation. The performance agreement was 100%., Conclusions: Thai transgender women had high acceptability and satisfaction towards self-collection for CT/NG testing. The performance was promising compared to provider collection. Our results support the implementation of self-collection to the sexually transmitted infection services, particularly during the COVID-19 pandemic where physical distancing is the new normal. A larger study is warranted to determine the performance of self-collection for CT/NG testing in each anatomical compartment and confirm the performance between self-collection and provider collection., (© 2021 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society.)
- Published
- 2021
- Full Text
- View/download PDF
24. Neovaginal and Anal High-Risk Human Papillomavirus DNA Among Thai Transgender Women in Gender Health Clinics.
- Author
-
Uaamnuichai S, Panyakhamlerd K, Suwan A, Suwajo P, Phanuphak N, Ariyasriwatana C, Janamnuaysook R, Teeratakulpisarn N, Vasuratna A, and Taechakraichana N
- Subjects
- Adult, DNA, Female, Humans, Papillomaviridae genetics, Thailand epidemiology, Alphapapillomavirus, Papillomavirus Infections diagnosis, Papillomavirus Infections epidemiology, Transgender Persons, Uterine Cervical Neoplasms
- Abstract
Background: Although human papillomavirus (HPV)-related lesions in the neovagina of transgender women have been well documented, information on high-risk HPV (hrHPV) in the neovagina has been very limited. The objective of this study was to determine hrHPV DNA detection rate in the neovagina of transgender women., Methods: Neovaginal and anal swab were collected in liquid-based cytology fluid from transgender women visiting Gender Health Clinic and Tangerine Community Health Clinic in Bangkok, Thailand. Samples were processed for hrHPV DNA (reported as subtypes 16 and 18 or the pooled result of subtypes 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 66) by automated real-time polymerase chain reaction and for neovaginal cytology according to the Bethesda system. Demographic data and sexual history were obtained, and physical examination was conducted. HIV status was obtained from existing medical records., Results: Samples were collected from 57 transgender women (mean age, 30.4 years [interquartile range, 8 years]). From 35 of 57 valid neovaginal samples, 8 (20%) tested positive for hrHPV DNA. From 30 of 57 valid anal samples, 6 (19.4%) tested positive for hrHPV DNA. HIV status was known for 52 transgender women, 1 of which were HIV infected; neovaginal hrHPV was invalid in that patient., Conclusions: One of 5 transgender women visiting sexual health clinics in Bangkok was found to have hrHPV DNA in neovaginal and anal compartments. Studies are needed to look at incidence and persistence of hrHPV infection to inform anogenital precancerous and cancerous screening programs for transgender women., Competing Interests: Conflict of Interest and Sources of Funding: This research was funded by the Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University (grant number RA61/064). The authors declare no conflict of interest., (Copyright © 2021 American Sexually Transmitted Diseases Association. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
25. Uptake of Primary Care Services and HIV and Syphilis Infection among Transgender Women attending the Tangerine Community Health Clinic, Bangkok, Thailand, 2016 - 2019.
- Author
-
van Griensven F, Janamnuaysook R, Nampaisan O, Peelay J, Samitpol K, Mills S, Pankam T, Ramautarsing R, Teeratakulpisarn N, Phanuphak P, and Phanuphak N
- Subjects
- Cohort Studies, Cross-Sectional Studies, Female, Homosexuality, Male, Humans, Male, Prevalence, Primary Health Care, Public Health, Thailand epidemiology, HIV Infections diagnosis, HIV Infections drug therapy, HIV Infections epidemiology, Syphilis diagnosis, Syphilis epidemiology, Transgender Persons
- Abstract
Introduction: Transgender women (TGW) need a specific package of primary care services usually not available in the publicly funded healthcare system. In addition, little is known about HIV and syphilis prevalence and incidence in clinic-based samples of TGW. Here we evaluate the uptake of a transgender-specific package of primary care services by TGW in Bangkok, Thailand and assess HIV and syphilis prevalence and incidence among them., Methods: Open cohort study of TGW attending services at the Tangerine Community Health Clinic from 2016 to 2019. Cross-sectional and longitudinal analysis of routinely collected clinic data was performed to study trends in the number of clients, clinic visits and HIV and syphilis prevalence and incidence., Results: During the study period, 2947 TGW clients made a total of 5227 visits to Tangerine. The number of clients significantly increased from 446 in 2016 to 1050 in 2019 (p < 0.001) and the number of visits from 616 to 2198 during the same period (p < 0.001). Prevalence of HIV at first visit was 10.8% and of syphilis 9.8%. HIV incidence was 1.03 per 100 person years (PY) and of syphilis 2.06 per 100 PY of follow-up. From 2016 to 2019, significant decreases occurred in the annual prevalence of HIV from 14.6% to 9.9% (p < 0.01). The annual prevalence of syphilis significantly increased from 6.6% in 2016 to 14.6% in 2018, and then decreased to 7.3% in 2019 (p < 0.001). The annual HIV incidence decreased during 2016 to 2019, from 1.68 to 1.28 per 100 PY, but this reduction was not statistically significant. The annual incidence of treponemal test seroconversion significantly increased from zero in 2016 to 4.55 per 100 PY in 2019 (p < 0.001)., Conclusions: The increasing uptake of a transgender-specific package of services, including co-located gender affirmative hormone therapy, suggests this may be an effective model in engaging and retaining TGW in primary care. The decrease in HIV prevalence and low HIV incidence across calendar years point at a possible reduction of HIV acquisition among the TGW population served by Tangerine. The increasing prevalence of syphilis suggests ongoing high-risk sexual behaviour and underscores the need for screening and treatment for this infection at the time of delivery of HIV services., (© 2021 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society.)
- Published
- 2021
- Full Text
- View/download PDF
26. Increased Burden of Concordant and Sequential Anogenital Human Papillomavirus Infections Among Asian Young Adult Women With Perinatally Acquired HIV Compared With HIV-Negative Peers.
- Author
-
Sohn AH, Chalermchockcharoenkit A, Teeraananchai S, Hansudewechakul R, Gatechompol S, Chokephaibulkit K, Dang HLD, Tran DNH, Achalapong J, Teeratakulpisarn N, Thamkhantho M, Phanuphak N, Ananworanich J, Reiss P, and Kerr SJ
- Subjects
- Adolescent, Adult, Child, Early Detection of Cancer, Female, Humans, Papillomaviridae genetics, Prevalence, Risk Factors, Thailand epidemiology, Young Adult, HIV Infections epidemiology, Papillomavirus Infections epidemiology, Uterine Cervical Neoplasms epidemiology
- Abstract
Background: Youth with perinatally acquired HIV (YPHIV) are at higher risk for anogenital human papillomavirus (HPV) infection., Methods: We enrolled a cohort of YPHIV and HIV-negative youth in Thailand and Vietnam, matched by age and lifetime sex partners, and followed them up for 144 weeks (to 2017). Participants had annual pelvic examinations with samples taken for HPV genotyping. Concordant infection was simultaneous HPV detection in multiple anogenital compartments (cervical, vaginal, anal); sequential infection was when the same type was found in successive compartments (cervicovaginal to/from anal). Generalized estimating equations were used to assess factors associated with concordant infection, and Cox regression was used to assess factors associated with sequential infection., Results: A total of 93 YPHIV and 99 HIV-negative women were enrolled, with a median age of 19 years (interquartile range, 18-20 years). High-risk anogenital HPV infection was ever detected in 76 (82%) YPHIV and 66 (67%) HIV-negative youth during follow-up. Concordant anogenital high-risk HPV infection was found in 62 (66%) YPHIV versus 44 (34%) HIV-negative youth. Sequential cervicovaginal to anal high-risk HPV infection occurred in 20 YPHIV versus 5 HIV-negative youth, with an incidence rate of 9.76 (6.30-15.13) versus 2.24 (0.93-5.38) per 100 person-years. Anal to cervicovaginal infection occurred in 4 YPHIV versus 0 HIV-negative women, with an incidence rate of 1.78 (0.67-4.75) per 100 person-years. Perinatally acquired HIV was the one factor independently associated with both concordant and sequential high-risk HPV infection., Conclusions: Children and adolescents with perinatally acquired HIV should be prioritized for HPV vaccination, and cervical cancer screening should be part of routine HIV care for sexually active YPHIV., Competing Interests: Conflict of Interest and Sources of Funding: A.H.S. has received grant and travel support to her institution from ViiV Healthcare. J.A. has received honoraria for participating in advisory meetings for Gilead, ViiV Healthcare, Merck, Roche, and Abbvie. P.R.'s institution, outside of the scope of the current study, has received independent scientific grant support from Gilead, Janssen, Merck, and ViiV, and P.R. has served on scientific advisory boards for Gilead, ViiV, Merck, and Teva, for which honoraria were all paid to his institution., (Copyright © 2020 American Sexually Transmitted Diseases Association. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
27. FRAX score with and without bone mineral density: a comparison and factors affecting the discordance in osteoporosis treatment in Thais.
- Author
-
Teeratakulpisarn N, Charoensri S, Theerakulpisut D, and Pongchaiyakul C
- Subjects
- Absorptiometry, Photon, Aged, Bone Density, Cross-Sectional Studies, Humans, Risk Assessment, Risk Factors, Thailand epidemiology, Osteoporosis diagnostic imaging, Osteoporosis drug therapy, Osteoporosis epidemiology, Osteoporotic Fractures epidemiology
- Abstract
We investigate the rate of concordance between treatment recommendations of osteoporosis with 10-year probability of hip fracture calculated using FRAX scores with and without BMD. We found that predictions were concordant in 83.8% of patients. However, older age, lower BMD, and FRAX without BMD around the intervention threshold were associated with discordant results. In the discordant group, FRAX with BMD suggested treatment in more participants with lower age, higher BMI, and lower BMD when compared with FRAX without BMD., Introduction: The Fracture Risk Assessment Tool (FRAX) is used to calculate the 10-year probability of fracture using important clinical factors, with bone mineral density (BMD) as an optional input variable. We aimed to determine the rate of concordance between treatment recommendations of osteoporosis with 10-year probability of hip fracture calculated using FRAX scores with and without BMD and to identify relevant clinical risk factors associated with discordance., Methods: This was a cross-sectional study conducted in patients between 40 and 90 years of age who were screened for osteoporosis by BMD measurement using dual energy X-ray absorptiometry (DXA) from 2010 to 2018 at a university hospital in Thailand. A FRAX questionnaire was administered to determine demographic data and osteoporotic risk factors. FRAX scores with and without BMD were calculated for each participant using the Thai reference, and patients were categorized into either the treatment or non-treatment group based on a cut-off of 3% 10-year probability of hip fracture. When FRAX scores with and without BMD results were consistent, they were considered concordant. Otherwise, they were deemed discordant. Clinical risk factors were compared between the concordant and discordant groups., Results: A total of 3545 participants were included in the study. The majority (83.8%) were in the concordant group. However, older age, lower BMD, and FRAX without BMD around the intervention threshold were significantly associated with discordant results. In the discordant group, FRAX with BMD suggested treatment in more participants with lower age, higher BMI, and lower BMD when compared with FRAX without BMD., Conclusion: FRAX scores with and without BMD yielded concordant predictions regarding the 10-year probability of hip fracture suggesting pharmacological treatment. However, this concordance declined in elderly and osteoporotic participants and in those with FRAX without BMD around intervention threshold. BMD data may be required in these populations in order to facilitate accurate risk assessment.
- Published
- 2021
- Full Text
- View/download PDF
28. Incidence, Persistence, and Factors Associated With HPV Infection Among Male Adolescents With and Without Perinatally Acquired HIV Infection.
- Author
-
Gatechompol S, Teeratakulpisarn N, Wittawatmongkol O, Teeraananchai S, Kerr SJ, Chalermchockcharoenkit A, Thamkhantho M, Singtoroj T, Phanuphak N, Sohn AH, and Chokephaibulkit K
- Subjects
- Adolescent, Child, Coinfection epidemiology, Coinfection etiology, HIV Infections complications, Humans, Incidence, Infectious Disease Transmission, Vertical statistics & numerical data, Male, Papillomavirus Infections complications, Risk Factors, Thailand epidemiology, Vietnam epidemiology, Young Adult, HIV Infections epidemiology, Papillomavirus Infections epidemiology
- Abstract
Background: Infection with high-risk human papillomavirus (HR-HPV) has been shown to be more prevalent and persistent in female adolescents with HIV. However, data among male adolescents with perinatally acquired HIV (PHIV) are limited., Setting: We investigated the incidence and persistence of HR-HPV in anogenital compartments and associated factors among PHIV in comparison to HIV-uninfected (HU) male adolescents in Thailand., Methods: PHIV and HU males aged 12-24 years were enrolled. At baseline and 3 subsequent annual visits, specimens from the scrotum, penis, and anal area were obtained for HPV and other testing., Results: From June 2013 to October 2017, 49 PHIV and 47 HU male adolescents with a median age of 18 (interquartile range 17-20) years were enrolled. PHIV had higher incidence of any HR-HPV infection than HU adolescents {33.05 [95% confidence interval (CI): 20.82 to 52.46] vs. 15.73 [95% CI: 8.18 to 30.22] per 100 person-years, P = 0.04}. The persistence of any HR-HPV genotypes (detected at ≥2 annual visits) was not different by group (PHIV 27% vs. HU 23%, P = 0.75). Having ≥3 sex partners in past 6 months (adjusted prevalence ratio 2.39, 95% CI: 1.14 to 5.05; P = 0.02) and co-infection with other sexually transmitted infections (syphilis, chlamydia, and/or gonorrhea) were associated with persistent HR-HPV infection (adjusted prevalence ratio 6.21, 95% CI: 2.87 to 13.41; P < 0.001)., Conclusions: Thai PHIV male adolescents had a higher incidence of HR-HPV infection than those without HIV. Having multiple sex partners and co-infection with sexually transmitted infections was associated with persistent HR-HPV infection. These data demonstrate the need to prioritize PHIV male adolescents in routine and catch-up HPV vaccination programs.
- Published
- 2020
- Full Text
- View/download PDF
29. Incidence and Persistence of High-risk Anogenital Human Papillomavirus Infection Among Female Youth With and Without Perinatally Acquired Human Immunodefiency Virus Infection: A 3-year Observational Cohort Study.
- Author
-
Phanuphak N, Teeraananchai S, Hansudewechakul R, Gatechompol S, Chokephaibulkit K, Dang HLD, Tran DNH, Achalapong J, Teeratakulpisarn N, Chalermchockcharoenkit A, Thamkhantho M, Pankam T, Singtoroj T, Termrungruanglert W, Chaithongwongwatthana S, Kerr SJ, and Sohn AH
- Subjects
- Adolescent, Adult, Child, Cohort Studies, Female, Humans, Incidence, Papillomaviridae genetics, Prevalence, Risk Factors, Thailand, Young Adult, HIV Infections complications, HIV Infections epidemiology, Papillomavirus Infections complications, Papillomavirus Infections epidemiology
- Abstract
Background: Female youth with perinatally acquired human immunodeficiency virus (PHIV) may be at higher risk than uninfected youth for persistent anogenital human papillomavirus (HPV) infection, due to prolonged immunodeficiency., Methods: A 3-year cohort study was conducted between 2013 and 2017 among Thai and Vietnamese PHIV and HIV-uninfected females 12-24 years, matched by age group and number of lifetime sexual partners. For HPV genotyping, cervical and anal samples were obtained at baseline and annually. Vaginal samples were collected at baseline and every 6 months. Factors associated with high-risk HPV (HR-HPV) persistence and incidence were assessed., Results: We enrolled 93 PHIV and 99 HIV-uninfected females. Median age was 19 (interquartile range [IQR] 18-20) years. For the 7 HR-HPV types (16, 18, 31, 33, 45, 52, 58) in the nonavalent HPV vaccine, PHIV had significantly higher incidence (P = .03) and persistence (P = .01) than HIV-uninfected youth over a 3-year period. Having HIV (adjusted hazard ratio [aHR] 2.1, 95% confidence interval [CI] 1.1-3.9) and ever using illegal substances (aHR 4.8, 95% CI 1.8-13.0) were associated with incident 7 HR-HPV infections. HIV-positive status (adjusted prevalence ratio [aPR] 2.2, 95% CI 1.5-3.2), recent alcohol use (aPR 1.75, 95% CI 1.2-2.5), and higher number of lifetime partners (aPR 2.0, 95% CI 1.4-3.1, for 3-5 partners; aPR 1.93, 95% CI 1.2-3.2, for ≥6 partners) were significantly associated with persistent 7 HR-HPV infections., Conclusions: Female PHIV were at higher risk of having anogenital HR-HPV acquisition and persistence. Primary and secondary prevention programs for HPV infection and HPV-related diseases should be prioritized for PHIV children and youth., (© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.)
- Published
- 2020
- Full Text
- View/download PDF
30. Incidence, clearance, persistence and factors related with high-risk anal HPV persistence in South-East Asian MSM and transgender women.
- Author
-
Yunihastuti E, Teeratakulpisarn N, Jeo WS, Nilasari H, Rachmadi L, Somia IKA, Sukmawati MDD, Amijaya KAT, Yee IA, Hairunisa N, Hongchookiat P, Trachunthong D, Pankam T, Nonenoy S, Ramautarsing R, Azwa I, Merati TP, Phanuphak P, Phanuphak N, and Palefsky JM
- Subjects
- Adolescent, Adult, Aged, Female, Humans, Incidence, Indonesia epidemiology, Malaysia epidemiology, Male, Papillomaviridae genetics, Papillomavirus Infections complications, Prevalence, Prospective Studies, Risk Factors, Thailand epidemiology, Anal Canal virology, HIV Seronegativity, Homosexuality, Male, Papillomaviridae isolation & purification, Papillomavirus Infections epidemiology, Transgender Persons
- Abstract
Objectives: Persistent anal high-risk human papillomavirus (HR-HPV) infection is a major risk factor for anal cancer among MSM and transgender women (TGW). We aimed to estimate incidence, clearance, and persistence of anal HR-HPV in HIV-positive and HIV-negative MSM and TGW, and to assess factors for HR-HPV persistence., Design: Prospective cohort study., Methods: MSM and TGW aged at least 18 years, were enrolled from Indonesia, Malaysia, and Thailand, then followed up 6-monthly for 12 months. Anal swabs were collected at every visit for HR-HPV genotypes to define anal HR-HPV incidence, clearance, and persistence. Logistic regression was used to evaluate factors associated with HR-HPV persistence., Results: Three hundred and twenty-five MSM and TGW were included in this study, of whom 72.3% were HIV-positive. The incidence of anal HR-HPV persistence was higher in HIV-positive than HIV-negative MSM participants (28.4/1000 vs. 13.9/1000 person-months). HIV-positive participants had HR-HPV lower clearance rate than HIV-negative participants (OR 0.3; 95% CI 0.1-0.7). The overall persistence of HR-HPV was 39.9% in HIV-positive and 22.8% HIV-negative participants. HPV-16 was the most persistent HR-HPV in both HIV-positive and HIV-negative participants. HIV infection (aOR 2.87; 95% CI 1.47-5.61), living in Kuala Lumpur (aOR 4.99; 95% CI 2.22-11.19) and Bali (aOR 3.39; 95% CI 1.07-10.75), being employed/freelance (aOR 3.99; 95% CI 1.48-10.77), and not being circumcised (aOR 2.29; 95% CI 1.07-4.88) were independently associated with anal HR-HPV persistence., Conclusion: HIV-positive MSM and TGW had higher risk of persistent anal HR-HPV infection. Prevention program should be made available and prioritized for HIV-positive MSM and TGW where resources are limited.
- Published
- 2020
- Full Text
- View/download PDF
31. Antiretroviral-naïve HIV-infected patients had lower bone formation markers than HIV-uninfected adults.
- Author
-
Wattanachanya L, Jantrapakde J, Avihingsanon A, Ramautarsing R, Kerr S, Trachunthong D, Pussadee K, Teeratakulpisarn N, Jadwattanakul T, Chaiwatanarat T, Buranasupkajorn P, Phanuphak N, Sunthornyothin S, and Phanuphak P
- Subjects
- Absorptiometry, Photon, Adult, Anti-HIV Agents therapeutic use, Anti-Retroviral Agents, Case-Control Studies, Collagen Type I blood, Female, Femur Neck diagnostic imaging, HIV Infections blood, HIV Infections drug therapy, Hip Joint diagnostic imaging, Humans, Lumbar Vertebrae diagnostic imaging, Male, Middle Aged, Osteocalcin blood, Peptide Fragments blood, Peptides blood, Procollagen blood, Prospective Studies, Thailand epidemiology, Vitamin D blood, Biomarkers blood, Bone Density drug effects, Bone Remodeling drug effects, HIV Infections diagnosis, Osteogenesis drug effects, Vitamin D analogs & derivatives
- Abstract
There are limited studies regarding bone health among people living with HIV (PLHIV) in Asia. We compared bone mineral density (BMD), serum 25-hydroxyvitamin D (25(OH)D) status and bone turnover markers (serum procollagen type1 N-terminal propeptide (P1NP), osteocalcin (OC) and C-terminal cross-linking telopeptide of type1 collagen) among 302 antiretroviral therapy (ART) naive PLHIV compared to 269 HIV-uninfected controls from Thailand. People aged ≥30 years, with and without HIV infection (free of diabetes, hypertension, and active opportunistic infection) were enrolled. BMD at the lumbar spine, total hip, and femoral neck were measured using Hologic DXA at baseline and at 5 years. We analyzed BMD, serum 25(OH)D levels, and bone turnover markers at the patients' baseline visit. PLHIV were 1.5 years younger and had lower BMI. PLHIV had higher mean serum 25(OH)D level and similar BMD to the controls. Interestingly, PLHIV had significantly lower bone formation (serum P1NP and OC), particularly those with low CD4 count. Only a few participants had low bone mass. ARV naïve middle-aged PLHIV did not have lower BMD or lower vitamin D levels compared to the controls. However, PLHIV had lower bone formation markers, particularly those with low CD4 count. This finding supports the benefit of early ART.
- Published
- 2020
- Full Text
- View/download PDF
32. Prospective International Study of Incidence and Predictors of Immune Reconstitution Inflammatory Syndrome and Death in People Living With Human Immunodeficiency Virus and Severe Lymphopenia.
- Author
-
Sereti I, Sheikh V, Shaffer D, Phanuphak N, Gabriel E, Wang J, Nason MC, Roby G, Ngeno H, Kirui F, Pau A, Mican JM, Rupert A, Bishop R, Agan B, Chomchey N, Teeratakulpisarn N, Tansuphaswadikul S, Langat D, Kosgei J, French M, Ananworanich J, and Sawe F
- Subjects
- Adult, CD4 Lymphocyte Count, Female, HIV, Humans, Incidence, Kenya, Male, Prospective Studies, Thailand, HIV Infections complications, HIV Infections drug therapy, Immune Reconstitution Inflammatory Syndrome epidemiology, Lymphopenia epidemiology
- Abstract
Background: Patients living with human immunodeficiency virus (PLWH) with low CD4 counts are at high risk for immune reconstitution inflammatory syndrome (IRIS) and death at antiretroviral therapy (ART) initiation., Methods: We investigated the clinical impact of IRIS in PLWH and CD4 counts <100 cells/μL starting ART in an international, prospective study in the United States, Thailand, and Kenya. An independent review committee adjudicated IRIS events. We assessed associations between baseline biomarkers, IRIS, immune recovery at week 48, and death by week 48 with Cox models., Results: We enrolled 506 participants (39.3% were women). Median age was 37 years, and CD4 count was 29 cells/μL. Within 6 months of ART, 97 (19.2%) participants developed IRIS and 31 (6.5%) died. Participants with lower hemoglobin at baseline were at higher IRIS risk (hazard ratio [HR], 1.2; P = .004). IRIS was independently associated with increased risk of death after adjustment for known risk factors (HR, 3.2; P = .031). Being female (P = .004) and having a lower body mass index (BMI; P = .003), higher white blood cell count (P = .005), and higher D-dimer levels (P = .044) were also significantly associated with increased risk of death. Decision-tree analysis identified hemoglobin <8.5 g/dL as predictive of IRIS and C-reactive protein (CRP) >106 μg/mL and BMI <15.6 kg/m2 as predictive of death., Conclusions: For PLWH with severe immunosuppression initiating ART, baseline low BMI and hemoglobin and high CRP and D-dimer levels may be clinically useful predictors of IRIS and death risk., (Published by Oxford University Press for the Infectious Diseases Society of America 2019.)
- Published
- 2020
- Full Text
- View/download PDF
33. Prevalence of High-risk Nonavalent Vaccine-type Human Papillomavirus Infection Among Unvaccinated, Sexually Active Asian Female Adolescents With and Without Perinatally Acquired HIV Infection.
- Author
-
Sricharoenchai S, Kerr SJ, Gatechompol S, Hansudewechakul R, Dang HLD, Tran DNH, Teeratakulpisarn N, Chalermchockcharoenkit A, Achalapong J, Teeraananchai S, Singtoroj T, Phanuphak N, Sohn AH, and Chokephaibulkit K
- Subjects
- Adolescent, Antibodies, Viral blood, Cohort Studies, Female, HIV Infections virology, Humans, Papillomaviridae classification, Papillomaviridae isolation & purification, Papillomavirus Vaccines administration & dosage, Prevalence, Sexually Transmitted Diseases blood, Sexually Transmitted Diseases epidemiology, Sexually Transmitted Diseases virology, Thailand epidemiology, Vietnam epidemiology, Young Adult, HIV Infections epidemiology, Infectious Disease Transmission, Vertical, Papillomaviridae genetics, Papillomavirus Infections epidemiology, Sexual Behavior statistics & numerical data
- Abstract
Background: We studied the prevalence of 7, high-risk human papillomavirus (HPV) types in the nonavalent vaccine (HRVT-7: HPV 16, 18, 31, 33, 45, 52, 58) among vaccine-naïve, sexually active Asian female adolescents with and without perinatally acquired HIV infection (PHIV)., Methods: PHIV female adolescents 12-24 years of age and HIV-uninfected controls matched by age and number of lifetime sex partners were enrolled in a 3-year observational cohort study in Thailand and Vietnam. Samples from the oral cavity, anus, cervix and vagina were collected for HRVT-7 HPV genotyping, and serum collected for HPV 16 and 18 antibody testing. Baseline data were analyzed using multivariable logistic regression., Results: We included 93 PHIV (median CD4 593 cells/mm, 62% with HIV RNA suppression) and 99 HIV-uninfected adolescents (median lifetime sex partners 2). The overall prevalence of HRVT-7 infection was 53% in PHIV and 49% in HIV-uninfected adolescents (P = 0.66). Cervical HRVT-7 DNA was detected more frequently in PHIV than HIV-uninfected adolescents (37% vs. 23%, P = 0.04). Overall, more lifetime partners [≥3 vs. 1; odds ratio (OR) 2.99 (1.38-6.51), P = 0.02] and having other sexually transmitted infections [OR 3.30 (1.51-7.21), P = 0.003] increased the risk of HRVT-7 infection and/or positive HPV 16/18 antibodies; while detectable HIV RNA [OR 2.78 (1.05-7.36), P = 0.04] increased the risk among PHIV adolescents., Conclusions: Half of sexually active Asian female adolescents, regardless of HIV infection, had already acquired HRVT-7 infection. This underscores the need for earlier access to HPV vaccine in the region.
- Published
- 2020
- Full Text
- View/download PDF
34. Bone mineral density changes among people living with HIV who have started with TDF-containing regimen: A five-year prospective study.
- Author
-
Han WM, Wattanachanya L, Apornpong T, Jantrapakde J, Avihingsanon A, Kerr SJ, Teeratakulpisarn N, Jadwattanakul T, Chaiwatanarat T, Buranasupkajorn P, Ramautarsing R, Phanuphak N, Sunthornyothin S, Ruxrungtham K, and Phanuphak P
- Subjects
- Absorptiometry, Photon, Adult, Female, Femur Neck, Humans, Male, Middle Aged, Osteoporosis chemically induced, Osteoporosis prevention & control, Prevalence, Prospective Studies, Thailand epidemiology, Anti-HIV Agents adverse effects, Bone Density drug effects, HIV Infections drug therapy, Osteoporosis epidemiology, Tenofovir adverse effects
- Abstract
There are limited data regarding long-term BMD changes over time among treatment-naïve people living with HIV (PLHIV) after initiating combined antiretroviral therapy (cART) in Asia. We aimed to study bone mineral density (BMD) changes among treatment-naïve PLHIV started treatment with tenofovir disoproxil fumarate (TDF)- or non-TDF-containing regimen and HIV-uninfected controls in an Asian setting. The study was a five-year prospective study. BMD at lumbar spine (LS) (L1 to L4), total hip (TH), and femoral neck (FN) were measured by dual energy X-ray absorptiometry (DEXA) scans at baseline, months 12, 24 and 60. Multivariate logistic regression models were used to explore factors associated with mean BMD ≥5% reduction after 5 years of cART. A total of 106 PLHIV (75 and 31 started TDF- and non-TDF-containing regimen, respectively) and 66 HIV-uninfected individuals were enrolled. The mean percent changes of BMD were significantly different longitudinally between TDF and non-TDF users (p<0.001 for LS, p = 0.006 for TH and p = 0.02 for FN). HIV-positive status and on TDF-containing regimen was independently associated with BMD loss ≥5% at month 60 (adjusted odds ratio [aOR] 7.0, 95% confidence interval [95%CI] 2.3-21.0, P = 0.001 for LS; aOR 4.9, 95%CI 1.7-14.3, P = 0.003 for TH and aOR 4.3, 95%CI 1.6-11.2, P = 0.003 for FN) compared to HIV-uninfected individuals. In a multivariate model for PLHIV only, TDF use (vs. non-TDF, P = 0.005) and pre-treatment CD4+ count <350 cells/mm3 (vs. ≥350 cells/mm3, P = 0.02) were independently associated with ≥5% BMD loss in TH at month 60. Treatment-naïve PLHIV initiating treatment with TDF-containing regimen have higher BMD loss in a Thai cohort. TDF use and low pre-treatment CD4 count were independently associated with BMD loss at month 60 at TH. Earlier treatment initiation and interventions to prevent bone loss could improve skeletal health among PLHIV. Clinicaltrials.gov: NCT01634607., Competing Interests: KR received honoraria or consultation fees from Merck, Roche, Jensen-Cilag, Johnson & Johnson, Mylan and GPO (Governmental pharmaceutical organization, Thailand); participated in a company sponsored speaker’s bureau from Abbott, Gilead, Bristol- Myers Squibb, Merck, Roche, Jensen-Cilag, ViiV Healthcare, and GPO (Governmental pharmaceutical organization); and received Chulalongkorn Academic Advancement into Its 2nd Century Project (CUAASC). AA has received honorarium for consultation from ViiV Healthcare. We confirm that the competing interests stated do not alter our adherence to PLOS ONE policies on sharing data and materials. The rest of the authors declare no competing interests.
- Published
- 2020
- Full Text
- View/download PDF
35. Changes in risk behaviors among Thai men who have sex with men and transgender women enrolled in the test and treat cohort.
- Author
-
Hiransuthikul A, Trachunthong D, Pattanachaiwit S, Teeratakulpisarn N, Chamnan P, Pathipvanich P, Thongpaen S, Pengnonyang S, Nonenoy S, Lertpiriyasuwat C, Phanuphak P, and Phanuphak N on behalf of the Thai MSM/TGW Test and Treat Study Group
- Subjects
- Adult, Cohort Studies, Female, Humans, Longitudinal Studies, Male, Thailand epidemiology, Young Adult, HIV Infections epidemiology, HIV Infections prevention & control, Homosexuality, Male statistics & numerical data, Risk-Taking, Sexual and Gender Minorities statistics & numerical data, Transgender Persons statistics & numerical data
- Abstract
The test-and-treat approach has the potential to reduce high-risk sexual behaviors by linking high-risk individuals to health education, although this has not been proven yet. We used longitudinal data from the Test and Treat Demonstration Project among Thai men who have sex with men (MSM) and transgender women (TGW) who were not known to be HIV-positive to analyze changes in risk behaviors during the 24-month study period categorized by three groups: HIV-negative without seroconversion, seroconverters, and HIV-positive at enrollment. Five binary risk behavior outcomes - laboratory-diagnosed sexually transmitted infections (STIs); multiple sexual partners, unprotected anal intercourse, self-perceived HIV risk, and amphetamine-type stimulants use in the past month - were assessed. Among 689 participants, with a mean (SD) age of 23.1 (6.2) years, 165 participants were diagnosed with HIV: 115 at enrollment and 50 with seroconversions. HIV-positive participants at enrollment showed significant reductions in all five behavioral risk outcomes. Seroconverters demonstrated higher risks at enrollment than HIV-negative participants, and continued to practice high-risk behaviors even after seroconversion despite a significant reduction in self-perceived moderate-to-high HIV risk. Continuation of risk behaviors among seroconverters could negatively affect the ending AIDS goal, thus the integration of other effective preventive measures into HIV/STIs management programs are needed.
- Published
- 2019
- Full Text
- View/download PDF
36. Human papillomavirus infection among male adolescents and young adults with perinatally-acquired HIV and without HIV in Thailand.
- Author
-
Wittawatmongkol O, Gatechompol S, Kerr SJ, Chalermchockcharoenkit A, Teeratakulpisarn N, Lermankul W, Thamkhantho M, Phanuphak N, Sohn AH, and Chokephaibulkit K
- Subjects
- Adolescent, Case-Control Studies, HIV Infections epidemiology, Humans, Male, Papillomaviridae genetics, Papillomavirus Infections diagnosis, Papillomavirus Infections drug therapy, Penis virology, Polymerase Chain Reaction, Prevalence, Prospective Studies, Rectum virology, Scrotum virology, Thailand epidemiology, Young Adult, Antiretroviral Therapy, Highly Active methods, HIV Infections complications, HIV Infections drug therapy, Infectious Disease Transmission, Vertical, Papillomaviridae isolation & purification, Papillomavirus Infections epidemiology
- Published
- 2019
- Full Text
- View/download PDF
37. High subsequent and recurrent sexually transmitted infection prevalence among newly diagnosed HIV-positive Thai men who have sex with men and transgender women in the Test and Treat cohort.
- Author
-
Hiransuthikul A, Pattanachaiwit S, Teeratakulpisarn N, Chamnan P, Pathipvanich P, Thongpaen S, Pengnonyang S, Trachunthong D, Nonenoy S, Lertpiriyasuwat C, Phanuphak P, and Phanuphak N
- Subjects
- Adult, Chlamydia Infections diagnosis, Female, Follow-Up Studies, Gonorrhea diagnosis, HIV Infections diagnosis, Humans, Male, Middle Aged, Prevalence, Recurrence, Sexually Transmitted Diseases diagnosis, Syphilis diagnosis, Thailand epidemiology, Transgender Persons, Young Adult, Chlamydia Infections epidemiology, Gonorrhea epidemiology, HIV Infections epidemiology, Homosexuality, Male, Sexually Transmitted Diseases epidemiology, Syphilis epidemiology, Transsexualism
- Abstract
We determined subsequent and recurrent sexually transmitted infections (STIs) among men who have sex with men (MSM) and transgender women (TGW) in the Test and Treat cohort. Thai MSM and TGW adults with previously unknown HIV status were enrolled and tested for HIV. Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and syphilis were tested at baseline, month 12, and month 24 to identify subsequent STIs (any STIs diagnosed after baseline) and recurrent STIs (any subsequent STIs diagnosed among those with positive baseline STIs). Among 448 participants, 17.8% were HIV-positive, the prevalence of subsequent STIs and recurrent STIs was 42% (HIV-positive versus HIV-negative: 66.3% versus 36.7%, p < 0.001) and 62.3% (81% versus 52.5%, p < 0.001), respectively. Common subsequent STIs by anatomical site were rectal CT infection (21.7%), rectal NG infection (13.8%), pharyngeal NG infection (13.1%), and syphilis (11.9%). HIV-positive status was associated with both subsequent STIs (adjusted hazard ratio [aHR] 2.38; 95%CI 1.64-3.45, p < 0.001) and recurrent STIs (aHR 1.83; 95%CI 1.16-2.87, p = 0.01). The results show that newly diagnosed HIV-positive MSM and TGW were at increased risk of STIs despite being in the healthcare system. STI educational counseling is necessary to improve STI outcomes among MSM and TGW in both HIV prevention and treatment programs.
- Published
- 2019
- Full Text
- View/download PDF
38. Use of copper intrauterine device is not associated with higher bacterial vaginosis prevalence in Thai HIV-positive women.
- Author
-
Kancheva Landolt N, Chaithongwongwatthana S, Nilgate S, Teeratakulpisarn N, Ubolyam S, Apornpong T, Ananworanich J, and Phanuphak N
- Subjects
- Adult, Cross-Sectional Studies, Female, Humans, Prevalence, Thailand, Vaginosis, Bacterial etiology, HIV Infections complications, Intrauterine Devices, Copper adverse effects, Vaginosis, Bacterial epidemiology
- Abstract
The study assessed and compared bacterial vaginosis (BV) prevalence in Thai women in reproductive age in four study groups - group 1, HIV-positive with copper intrauterine device (Cu-IUD); group 2, HIV-positive without Cu-IUD; group 3, HIV-negative with Cu-IUD; and group 4, HIV-negative without Cu-IUD. We conducted a cross-sectional study. BV prevalence was assessed by Nugent score and Amsel criteria. Descriptive statistics was used to present baseline characteristics; kwallis rank test - to compare variables between the four groups; logistic regression - to assess factors, related to BV prevalence. The analysis included 137 women in the four study groups with a median age of 39 years. Median BV prevalence by Nugent score was 45%, intermediate vaginal flora - 7% and normal vaginal flora - 48%. There was no statistically significant difference in the BV prevalence between the four study groups, p = 0.711. Threefold lower BV prevalence was found, assessed by Amsel criteria compared to Nugent score. Women with body mass index (BMI) < 20 had higher probability to have BV or intermediate vaginal flora, OR = 3.11, 95% CI (1.2-8.6), p = 0.025. The study found a high BV prevalence in the four study groups, related neither to HIV status, nor to Cu-IUD use. BV prevalence was associated only with low BMI. Thus, Cu-IUD could be a good contraceptive choice for HIV-positive women. Research in defining normal vaginal microbiota and improve diagnostic methods for BV should continue.
- Published
- 2018
- Full Text
- View/download PDF
39. Sexually transmitted infections and HIV RNA levels in blood and anogenital compartments among Thai men who have sex with men before and after antiretroviral therapy: implication for Treatment as Prevention programme.
- Author
-
Phanuphak N, Pattanachaiwit S, Pankam T, Teeratakulpisarn N, Chamnan P, Pathipvanich P, Thongpaen S, Nonenoy S, Jantarapakde J, Pengnonyang S, Trachunthong D, Sungsing T, Parasate K, Seeneewong Na Ayutthaya S, Trairat K, Pussadee K, Lertpiriyasuwat C, and Phanuphak P
- Subjects
- Adolescent, Adult, Anti-Retroviral Agents administration & dosage, Anti-Retroviral Agents therapeutic use, Cohort Studies, HIV Infections drug therapy, Humans, Incidence, Male, Prevalence, Rectum virology, Risk-Taking, Semen virology, Sexual Behavior, Sexual Partners, Thailand epidemiology, HIV Infections epidemiology, HIV Infections virology, Homosexuality, Male statistics & numerical data, RNA, Viral blood, RNA, Viral isolation & purification
- Abstract
Introduction: Sexually transmitted infections (STIs) are common among HIV-positive men who have sex with men (MSM). There have been concerns that undiagnosed and untreated STIs could undermine efforts to use antiretroviral therapy (ART) for prevention due to genital secretion infectiousness. We evaluated the correlation between STIs and HIV RNA in anogenital compartments among HIV-positive MSM before and after ART., Methods: MSM participants newly diagnosed with HIV were offered ART regardless of CD4 count during November 2012 to November 2015. Syphilis serology, oropharyngeal swab, rectal swab, urine collection for gonorrhoea and chlamydia nucleic acid amplification testing, and HIV RNA measurement in blood, semen and rectal samples were performed at baseline, 12 and 24 months thereafter., Results: Of 143 HIV-positive MSM, 16.1% had syphilis, 23.1% had gonorrhoea and 32.8% had chlamydia at baseline. Participants with STIs at baseline had higher median HIV RNA levels in blood plasma (p = 0.053), seminal plasma (p = 0.01) and rectal secretions (p = 0.002) than those without STIs. Multivariate models identified HIV RNA 100,000 to 500,000 (OR 6.74, 95% CI 2.24 to 20.28, p = 0.001) and >500,000 (OR 9.39, 95% CI 1.08 to 81.72, p = 0.04) copies/mL in blood, CD4 count <350 cells/mm
3 (OR 4.20, 95% CI 1.05 to 16.70, p = 0.04) and having any STIs (OR 2.62, 95% CI 1.01 to 6.80 p = 0.047) to be associated with detectable (>40 copies/mL) seminal plasma HIV RNA. Having chlamydia at any sites (OR 3.17, 95% CI 1.07 to 9.44, p = 0.04) was associated with detectable rectal HIV RNA. Incidences of syphilis, gonorrhoea and chlamydia were 13.4, 16.4 and 18.1 per 100 person-years respectively. Nine participants had detectable HIV RNA (five in blood, one in semen, two in rectal samples and one in both blood and rectal samples) at 12 and/or 24 months after ART., Conclusions: STIs were extremely common among HIV-positive MSM prior to and after ART. ART effectively reduced HIV RNA in all compartments. The correlation between STIs and anogenital HIV RNA, especially prior to ART and likely until complete HIV RNA suppression from ART is achieved, points to the importance of integrating asymptomatic STIs screening into Treatment as Prevention programme for MSM., (© 2018 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society.)- Published
- 2018
- Full Text
- View/download PDF
40. Risk Factors for Human Papillomavirus Infection and Abnormal Cervical Cytology Among Perinatally Human Immunodeficiency Virus-Infected and Uninfected Asian Youth.
- Author
-
Sohn AH, Kerr SJ, Hansudewechakul R, Gatechompol S, Chokephaibulkit K, Dang HLD, Tran DNH, Achalapong J, Teeratakulpisarn N, Chalermchockcharoenkit A, Thamkhantho M, Pankam T, Singtoroj T, Termrungruanglert W, Chaithongwongwatthana S, and Phanuphak N
- Subjects
- Adolescent, CD4 Lymphocyte Count, Female, HIV isolation & purification, HIV Infections epidemiology, Humans, Longitudinal Studies, Pregnancy, Pregnancy Complications, Infectious epidemiology, Risk Factors, Sexually Transmitted Diseases epidemiology, Thailand epidemiology, Vaginal Smears, Vietnam epidemiology, Viral Load, Young Adult, Cervix Uteri pathology, HIV Infections complications, Papillomavirus Infections epidemiology, Pregnancy Complications, Infectious virology, Sexually Transmitted Diseases complications
- Abstract
Background: Infection with high-risk human papillomavirus (HR-HPV) may be higher in perinatally human immunodeficiency virus (HIV)-infected (PHIV) than HIV-uninfected (HU) adolescents because of long-standing immune deficiency., Methods: PHIV and HU females aged 12-24 years in Thailand and Vietnam were matched by age group and lifetime sexual partners. At enrollment, blood, cervical, vaginal, anal, and oral samples were obtained for HPV-related testing. The Wilcoxon and Fisher exact tests were used for univariate and logistic regression for multivariate analyses., Results: Ninety-three PHIV and 99 HU adolescents (median age 19 [18-20] years) were enrolled (June 2013-July 2015). Among PHIV, 94% were currently receiving antiretroviral therapy, median CD4 count was 593 (392-808) cells/mm3, and 62% had a viral load <40 copies/mL. Across anogenital compartments, PHIV had higher rates of any HPV detected (80% vs 60%; P = .003) and any HR-HPV (60% vs 43%, P = .02). Higher proportions of PHIV had abnormal Pap smears (eg, atypical squamous cells of unknown significance [ASC-US], 12% vs 14%; low-grade squamous intraepithelial neoplastic lesions, 19% vs 1%). After adjusting for ever being pregnant and asymptomatic sexually transmitted infections (STI) at enrollment, PHIV were more likely to have HR-HPV than HU (odds ratio, 2.02; 95% confidence interval, 1.09-3.77; P = .03)., Conclusions: Perinatal HIV infection was associated with a higher risk of HR-HPV and abnormal cervical cytology. Our results underscore the need for HPV vaccination for PHIV adolescents and for prevention and screening programs for HPV and other STIs.
- Published
- 2018
- Full Text
- View/download PDF
41. Prevalence of and risk factors for anal high-risk HPV among HIV-negative and HIV-positive MSM and transgender women in three countries at South-East Asia.
- Author
-
Somia IKA, Teeratakulpisarn N, Jeo WS, Yee IA, Pankam T, Nonenoy S, Trachuntong D, Mingkwanrungrueng P, Sukmawati MDD, Ramautarsing R, Nilasari H, Hairunisa N, Azwa I, Yunihastuti E, Merati TP, Phanuphak P, Palefsky J, and Phanuphak N
- Subjects
- Adult, Anal Canal virology, CD4 Lymphocyte Count, Female, HIV Infections blood, HIV Infections virology, HIV Seronegativity, HIV Seropositivity blood, HIV Seropositivity virology, Humans, Indonesia epidemiology, Malaysia epidemiology, Male, Middle Aged, Papillomaviridae, Papillomavirus Infections blood, Papillomavirus Infections virology, Prevalence, Prospective Studies, Risk Factors, Thailand epidemiology, HIV Infections epidemiology, HIV Seropositivity epidemiology, Papillomavirus Infections epidemiology, Sexual and Gender Minorities statistics & numerical data, Transgender Persons statistics & numerical data
- Abstract
This study aimed to assess the prevalence of and associated risk factors for anal high-risk human papillomavirus (hr-HPV) infection among men who have sex with men (MSM) and transgender women (TGW) in Indonesia, Thailand, and Malaysia.This was baseline data from a prospective cohort study with clinic sites in Jakarta and Bali (Indonesia), Bangkok (Thailand), and Kuala Lumpur (Malaysia).MSM and TGW aged 18 years and older from Indonesia, Thailand, and Malaysia were enrolled. Demographic and behavioral characteristics were assessed, and anal samples were collected for HPV genotyping. Multivariate logistic regression models were used to assess risk factors for anal hr-HPV overall and among HIV-positive participants.A total of 392 participants were enrolled, and 48 were TGW. As many as 245 were HIV-positive, and 78.0% of the participants were on combination antiretroviral therapy (cART). Median CD4 count was 439 cells/mm and 68.2% had undetectable HIV-RNA. HIV-positive participants had significantly more hr-HPV compared to HIV-negative participants (76.6% vs 53.5%, P < .001). HPV-16 was the most common high-risk type (20%), whereas HPV-33, -39, and -58 were significantly more common among HIV-positive participants. HIV-positive participant significantly associated with anal hr-HPV infection compared with HIV-negative (OR: 2.87, 95% CI: 1.76-4.70, P ≤ .001), whereas among HIV-positive participants transgender identity had lower prevalence of hr-HPV infection (OR: 0.42, 95% CI: 0.19-0.91, P = .03).High-risk HPV infection was very common among MSM and TGW in South-East Asia. Overall, HIV-infection, regardless of cART use and immune status, significantly increased the risk, while among HIV-positive participants transgender identity seemed to decrease the risk of anal hr-HPV.
- Published
- 2018
- Full Text
- View/download PDF
42. Factors associated with intention to take non-occupational HIV post-exposure prophylaxis among Thai men who have sex with men.
- Author
-
Chomchey N, Woratanarat T, Hiransuthikul N, Lertmaharit S, Lohsoonthorn V, Teeratakulpisarn N, Pinyakorn S, Fletcher JL, Suttichom D, Phanuphak P, Ananworanich J, and Phanuphak N
- Abstract
Background: Men who have sex with men (MSM) are disproportionately infected with HIV in Thailand. Factors affecting their intention to take non-occupational HIV post-exposure prophylaxis (nPEP) are not well understood. This study sought to determine factors associated with an intention to take nPEP in this population., Method: This is a two-phase mixed-method study. Phase I was a cross-sectional survey of intention to take nPEP in 450 MSM attending for HIV testing, using a self-administered questionnaire. Phase II was a prospective descriptive study, using an in-depth interview among 40 MSM who had been exposed to HIV in the past 72 hours. Multiple logistic regression was used to evaluate factors relating to the intention to use nPEP., Results: Among 450 MSM seeking HIV testing in Bangkok, 7% had ever taken nPEP. Only 40% expressed an intention to take it to prevent HIV acquisition, despite the fact that they were at high risk as evidenced by an 18.9% prevalence of HIV-positive status. Factors associated with an intention to take nPEP were awareness about nPEP, HIV knowledge, mode of sexual intercourse and circumcision. Among 40 MSM who were eligible for and offered nPEP, 39 agreed to take it, and all but one completed the 4-week course. Condom use increased and all 32 individuals who could be contacted tested HIV negative after nPEP., Conclusion: A high HIV prevalence was found in MSM testing for HIV in this study. However, fewer than half of the participants expressed the intention to take nPEP if they were at risk for HIV infection. Efforts to create nPEP awareness and improve HIV knowledge in MSM are crucial to the successful implementation of nPEP as part of a combination package for HIV prevention in this high-risk population.
- Published
- 2017
43. Distal leg epidermal nerve fiber density as a surrogate marker of HIV-associated sensory neuropathy risk: risk factors and change following initial antiretroviral therapy.
- Author
-
Shikuma CM, Bennett K, Ananworanich J, Gerschenson M, Teeratakulpisarn N, Jadwattanakul T, DeGruttola V, McArthur JC, Ebenezer G, Chomchey N, Praihirunkit P, Hongchookiat P, Mathajittiphun P, Nakamoto B, Hauer P, Phanuphak P, and Phanuphak N
- Subjects
- Adult, Cross-Sectional Studies, Female, Humans, Leg, Male, Risk Factors, Skin innervation, Stavudine adverse effects, Tenofovir adverse effects, Thailand, Zidovudine adverse effects, Anti-Retroviral Agents adverse effects, HIV Infections complications, HIV Infections drug therapy, Peripheral Nervous System Diseases etiology, Peripheral Nervous System Diseases pathology, Sensory Receptor Cells pathology
- Abstract
Distal leg epidermal nerve fiber density (ENFD) is a validated predictor of HIV sensory neuropathy (SN) risk. We assessed how ENFD is impacted by initiation of first-time antiretroviral therapy (ART) in subjects free of neuropathy and how it is altered when mitochondrial toxic nucleoside medications are used as part of ART. Serial changes in proximal thigh and distal leg ENFD were examined over 72 weeks in 150 Thai subjects randomized to a regimen of stavudine (d4T) switching to zidovudine (ZDV) at 24 weeks vs ZDV vs tenofovir (TDF) for the entire duration of study, all given in combination with nevirapine. We found individual variations in ENFD change, with almost equal number of subjects who decreased or increased their distal leg ENFD over 72 weeks and no relationship to nucleoside backbone or to development of neuropathic signs or symptoms. Lower baseline distal leg ENFD and greater increases in mitochondrial oxidative phosphorylation complex I (CI) activity were associated with larger increases in distal leg ENFD over 72 weeks. Distal leg ENFD correlated with body composition parameters (body surface area, body mass index, height) as well as with blood pressure measurements. Assessed together with a companion cross-sectional study, we found that mean distal leg ENFD in all HIV+ subjects was lower than in HIV- subjects but similar among HIV+ groups whether ART-naïve or on d4T with/without neuropathy/neuropathic symptoms. The utility of ENFD as a useful predictor of small unmyelinated nerve fiber damage and neuropathy risk in HIV may be limited in certain populations.
- Published
- 2015
- Full Text
- View/download PDF
44. Anogenital HIV RNA in Thai men who have sex with men in Bangkok during acute HIV infection and after randomization to standard vs. intensified antiretroviral regimens.
- Author
-
Phanuphak N, Teeratakulpisarn N, van Griensven F, Chomchey N, Pinyakorn S, Fletcher JL, Trichavaroj R, Pattanachaiwit S, Michael N, Phanuphak P, Kim JH, and Ananworanich J
- Subjects
- Acute Disease, Adult, HIV Infections virology, Humans, Male, Thailand, HIV Infections drug therapy, Homosexuality, Male, RNA, Viral analysis, Semen virology
- Abstract
Introduction: HIV transmission risk is highest during acute HIV infection (AHI). We evaluated HIV RNA in the anogenital compartment in men who have sex with men (MSM) during AHI and compared time to undetectable HIV RNA after three-drug versus five-drug antiretroviral therapy (ART) to understand risk for onward HIV transmission., Methods: MSM with AHI (n=54) had blood, seminal plasma and anal lavage collected for HIV RNA at baseline, days 3 and 7, and weeks 2, 4, 12 and 24. Data were compared between AHI stages: 1 (fourth-generation antigen-antibody combo immunoassay [IA]-, third-generation IA-, n=15), 2 (fourth-generation IA+, third-generation IA-, n=9) and 3 (fourth-generation IA+, third-generation IA+, western blot-/indeterminate, n=30) by randomization to five-drug (tenofovir+emtricitabine+efavirenz+raltegravir+maraviroc, n=18) versus three-drug (tenofovir+emtricitabine+efavirenz, n=18) regimens., Results: Mean age was 29 years and mean duration since HIV exposure was 15.4 days. Mean baseline HIV RNA was 5.5 in blood, 3.9 in seminal plasma and 2.6 log10 copies/ml in anal lavage (p<0.001). Blood and seminal plasma HIV RNA were higher in AHI Stage 3 compared to Stage 1 (p<0.01). Median time from ART initiation to HIV RNA <50 copies/ml was 60 days in blood, 15 days in seminal plasma and three days in anal lavage. Compared with the three-drug ART, the five-drug ART had a shorter time to HIV RNA <1500 copies/ml in blood (15 vs. 29 days, p=0.005) and <50 copies/ml in seminal plasma (13 vs. 24 days, p=0.048)., Conclusions: Among MSM with AHI, HIV RNA was highest in blood, followed by seminal plasma and anal lavage. ART rapidly reduced HIV RNA in all compartments, with regimen intensified by raltegravir and maraviroc showing faster HIV RNA reductions in blood and seminal plasma.
- Published
- 2015
- Full Text
- View/download PDF
45. Cervical and anal HPV infection: cytological and histological abnormalities in HIV-infected women in Thailand.
- Author
-
Ramautarsing RA, Phanuphak N, Chaithongwongwatthana S, Wit FW, Teeratakulpisarn N, Pankam T, Rodbamrung P, Wijgert JH, Lange JM, Phanuphak P, Sahasrabuddhe VV, Kerr S, and Ananworanich J
- Abstract
Background: Women infected with human immunodeficiency virus (HIV) have higher rates of persistent infection with high-risk human papillomavirus (hr-HPV) and cervical and anal dysplasia. We describe the epidemiology of hr-HPV, and cervical and anal intra-epithelial abnormalities in HIV-infected women in Thailand., Methods: HIV-infected women aged 18-49 years, either HAART-naïve or -experienced, were enrolled in Bangkok, Thailand. A demographic and sexual-risk behaviour questionnaire was administered and a pelvic examination with colposcopy was performed on every woman. Cervical and anal samples were tested for cytology and HPV genotyping., Results: A total of 256 women were enrolled with a median [interquartile range (IQR)] age of 35 (32-40) years. Ninety (35.2%) had detectable cervical hr-HPV. Being post-menopausal was associated with increased risk for cervical hr-HPV, while years since HIV diagnosis and plasma HIV RNA <40 copies/mL were significantly associated with decreased risk in multivariable regression analyses. Abnormal cervical cytology was detected in 6.3%. Cervical biopsies that were taken from 99 women (39.3%) owing to abnormalities seen during colposcopy showed cervical intra-epithelial neoplasia (CIN) in 22.6%. The sensitivity of cervical cytology to detect CIN2+ was 10.0%. Among 102 women enrolled in the anal substudy, 18.8% had anal HPV infection and 11.1% had anal hr-HPV. Two women had abnormal anal cytology., Conclusion: We found cervical and anal hr-HPV in 35.2% and 11.1% of Thai HIV-infected women, respectively. Moreover, the observed poor agreement between cervical cytology and histology results could indicate current cervical cancer screening programs for HIV-infected women might not be optimal for the detection of pre-neoplastic lesions.
- Published
- 2015
46. Low incidence of HIV infection in an anonymous HIV counselling and testing clinic cohort in Bangkok, Thailand despite high HIV prevalence and self-report of high-risk behaviour.
- Author
-
Phanuphak N, Paris R, Colby D, Pinyakorn S, Souza M, Teeratakulpisarn N, Chomchey N, Sutthichom D, Sukjitpaiboonphol A, Pankam T, Kim JH, Ananworanich J, and Phanuphak P
- Abstract
Background: HIV counselling and testing (HCT) clinics have the potential to be entry points for recruiting populations at high risk for HIV infection for HIV prevention and treatment studies. Cohort data from key populations are crucial for HIV study site selection., Method: This cohort study recruited clients at an HCT clinic in Bangkok, Thailand. HIV prevalence was assessed along with demographics, perception of risk and behavioural risk factors. Participants who were HIV negative at baseline were followed up every 4 months for up to 1 year to measure HIV incidence and changes in risk behaviour., Results: A total of 992 subjects enrolled; median age was 30 years, 27% were men who have sex with men (MSM) and 8% were commercial sex workers (CSW). Baseline HIV prevalence was 10%. Factors positively associated with HIV infection were age >30 years, lower educational status and being MSM. Factors negatively associated with HIV infection were self-perception of minimal or moderate risk. Overall dropout rate was 49%, with 24% not returning after enrolment. HIV incidence was lower than expected at 0.50 per 100 person-years overall and 1.95 per 100 person-years for MSM., Conclusions: This HCT population had a high baseline HIV prevalence but a low incidence rate on follow-up. Overall retention in the cohort was poor and may have resulted from suboptimal reminders and characteristics of high-risk clients who use anonymous HIV testing services. MSM had higher HIV incidence and better retention than other high-risk groups.
- Published
- 2015
47. Cervical cytological abnormalities and HPV infection in perinatally HIV-infected adolescents.
- Author
-
Ananworanich J, Prasitsuebsai W, Kerr SJ, Hansudewechakul R, Teeratakulpisarn N, Saisawat K, Ramautarsing R, Achalapong J, Pussadee K, Keadpudsa S, Mackay T, Pankam T, Rodbamrung P, Petdachai W, Chokephaibulkit K, Sohn AH, and Phanuphak N
- Abstract
Background: Behaviourally HIV-infected adolescent females are at higher risk for abnormal cervical cytology and HPV infection compared to those who are uninfected, but data on perinatally HIV-infected adolescent females are lacking., Methods: Cervical cytology, HPV infection and E6/E7 mRNA were assessed in sexually active 12-24-year-old adolescent females: perinatally HIV-infected (group 1, n = 40), behaviourally HIV-infected (group 2, n = 10), and HIV-uninfected (group 3, n = 10)., Results: Median age was lower in group 1 (18 years) than in groups 2 (24 years) and 3 (20.5 years) ( P < 0.001), and median time since sexual debut was shorter: 2 vs 5 vs 4 years ( P < 0.001). More trial participants in group 1 than group 2 were on antiretrovirals (90% vs 70%; P <0.001). Abnormal cervical cytology (atypical squamous cells of undetermined significance and higher) was observed in 30% (group 1), 40% (group 2) and 30% (group 3) ( P = 0.92), whereas high-risk HPV infection was observed in 45%, 45% and 40%, respectively ( P = 1.00). Positive E6/E7 mRNA was found in 28% of group 1, but not in other groups. High-risk HPV infection predicted abnormal cytology in all groups [OR 6.77, 95% confidence interval (CI) 1.99-23.0; P = 0.001). Additionally, plasma HIV RNA ≥50 copies/mL (OR 13.3, 95% CI 1.16-153.06; P = 0.04) predicted abnormal cytology in HIV-infected adolescent females., Conclusions: Despite the younger age and shorter time since sexual debut, cervical cytological abnormalities and HPV infection were as common in perinatally HIV-infected as in behaviourally infected and uninfected adolescents. HPV vaccination, pre-cancer screening and antiretroviral treatment in HIV-infected female adolescents should be implemented to minimise the risk of cervical cancer.
- Published
- 2015
48. Attitudes toward, and interest in, the test-and-treat strategy for HIV prevention among Thai men who have sex with men.
- Author
-
Maek-a-nantawat W, Phanuphak N, Teeratakulpisarn N, Pakam C, Kanteeranon T, Chaiya O, Mansawat T, Teeratakulpisarn S, Nonenoy S, Ananworanich J, and Phanuphak P
- Subjects
- Adult, HIV Infections drug therapy, HIV Seropositivity diagnosis, HIV Seropositivity drug therapy, Humans, Male, Surveys and Questionnaires, Thailand, Young Adult, Anti-HIV Agents therapeutic use, Attitude to Health, HIV Infections prevention & control, HIV Infections psychology, Health Knowledge, Attitudes, Practice, Homosexuality, Male psychology
- Abstract
This study assessed the attitudes toward, and interest in, the test-and-treat strategy, comprising regular HIV testing and immediate antiretroviral treatment (ART) among men who have sex with men (MSM) in Bangkok, Thailand. A total of 363 participants completed the questionnaires before and after learning about their HIV status. Previous HIV testing reported by 69.8% and 34.7% tested at least annually. Before pretest counseling, 83.2% expressed interest in regular HIV testing and 78.8% in immediate ART. MSM who tested HIV-positive at enrollment were less likely than those who tested HIV-negative to have been tested for HIV before (45.7% vs. 60.8%, p < 0.0001). Among MSM who tested HIV-positive (n = 69, 15.9%), the median level of willingness to take ART immediately increased significantly after learning about their positive results (90 vs.100%, p < 0.0001). Interest in regular HIV testing remained high among HIV-negative MSM after becoming aware of their status (70.9% before vs. 71.9% after, p = 0.55). MSM participants have a strong desire and willingness to start ART immediately upon receiving an HIV-positive test result; it is important to provide the necessary information on the health benefits of early ART and education to the community to maintain their health and prevent HIV transmission.
- Published
- 2014
- Full Text
- View/download PDF
49. Use of human papillomavirus DNA, E6/E7 mRNA, and p16 immunocytochemistry to detect and predict anal high-grade squamous intraepithelial lesions in HIV-positive and HIV-negative men who have sex with men.
- Author
-
Phanuphak N, Teeratakulpisarn N, Keelawat S, Pankam T, Barisri J, Triratanachat S, Deesua A, Rodbamrung P, Wongsabut J, Tantbirojn P, Numto S, Ruangvejvorachai P, Phanuphak P, Palefsky JM, Ananworanich J, and Kerr SJ
- Subjects
- Adult, Anal Canal pathology, Biomarkers metabolism, Cyclin-Dependent Kinase Inhibitor p16, DNA, Viral analysis, DNA, Viral genetics, Epithelial Cells virology, Genotyping Techniques, Humans, Immunohistochemistry, Male, Neoplasm Proteins immunology, Papillomaviridae genetics, Papillomaviridae physiology, Prevalence, RNA, Messenger genetics, RNA, Messenger metabolism, Risk, Anal Canal virology, Epithelial Cells pathology, HIV Seronegativity, HIV Seropositivity complications, Homosexuality, Male, Neoplasm Proteins analysis, Papillomaviridae isolation & purification, Papillomavirus E7 Proteins genetics
- Abstract
Background: Men who have sex with men (MSM) are at high risk of having anal cancer. Anal high-grade squamous intraepithelial lesion (HSIL) is the precursor of anal cancer. We explored the use of different biomarkers associated with human papillomavirus (HPV) infection and HPV-mediated cell transformation to detect and predict HSIL among HIV-positive and HIV-negative MSM., Methodology/principal Findings: A total of 123 HIV-positive and 123 HIV-negative MSM were enrolled and followed for 12 months. High-resolution anoscopy (HRA) with biopsies were performed at every visit along with anal sample collection for cytology, high-risk HPV DNA genotyping, HPV E6/E7 mRNA, and p16 immunocytochemistry. Performance characteristics and area under the receiver operator characteristics curve were calculated for these biomarkers at baseline, and Cox regression compared the usefulness of these biomarkers in predicting incident HSIL. High-risk HPV DNA, E6/E7 mRNA, and p16 immunocytochemistry each identified 43-46% of MSM whose baseline test positivity would trigger HRA referral. E6/E7 mRNA had the highest sensitivity (64.7%) and correctly classified the highest number of prevalent HSIL cases. With the exception of p16 immunochemistry, most tests showed significant increases in sensitivity but decreases specificity versus anal cytology, while the overall number of correctly classified cases was not significantly different. Baseline or persistent type 16 and/or 18 HPV DNA was the only test significantly predicting incident histologic HSIL within 12 months in models adjusted for HIV status and low-grade squamous intraepithelial lesions at baseline., Conclusions/significance: Countries with a high HIV prevalence among MSM and limited HRA resources may consider using biomarkers to identify individuals at high risk of HSIL. E6/E7 mRNA had the highest sensitivity for prevalent HSIL detection regardless of HIV status, whereas type 16 and/or 18 HPV DNA performed best in predicting development of incident HSIL within 12 months.
- Published
- 2013
- Full Text
- View/download PDF
50. Ethnic differences in epidermal nerve fiber density.
- Author
-
Shikuma CM, McArthur JC, Ebenezer GJ, Ananworanich J, Teeratakulpisarn N, Jadwattanakul T, Valcour VG, Bennett K, and Phanuphak N
- Subjects
- Adolescent, Adult, Age Factors, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Reference Values, United States, Young Adult, Nerve Fibers physiology, Skin innervation
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.